Split (1)

train · 500 rows

patient_id string	ild_subtype string	age_at_diagnosis float64	sex string	race_ethnicity string	smoking_status string	pack_years float64	occupational_exposure string	geographic_region string	bmi_at_diagnosis float64	height_cm float64	diagnosis_year int64	follow_up_months_available int64	icd11_code string	hrct_pattern string	fibrosis_extent_pct float64	honeycombing_flag int64	honeycombing_extent_pct float64	ground_glass_opacity_pct float64	traction_bronchiectasis_score float64	subpleural_distribution string	reticulation_extent_pct float64	air_trapping_flag int64	mosaic_attenuation_flag int64	hrct_progression_score_annual_pct float64	imaging_ai_fibrosis_score float64	imaging_platform string	slice_thickness_mm float64	fvc_pct_predicted_baseline float64	fvc_absolute_liters_baseline float64	fvc_decline_ml_per_year float64	dlco_pct_predicted_baseline float64	dlco_decline_pct_per_year float64	tlc_pct_predicted float64	rv_tlc_ratio float64	fev1_fvc_ratio float64	six_min_walk_distance_m int64	six_min_walk_spo2_nadir_pct float64	spo2_at_rest_pct float64	supplemental_oxygen_flag int64	supplemental_oxygen_lpm float64	fvc_response_category string	gap_index int64	composite_physiologic_score float64	loinc_fvc_pct string	loinc_dlco_pct string	treatment_arm string	pirfenidone_dose_mg_day int64	nintedanib_dose_mg_day int64	treatment_start_months_from_dx float64	antifibrotic_adherence_pct float64	dose_reduction_flag int64	treatment_discontinuation_flag int64	discontinuation_reason string	time_to_discontinuation_months float64	fvc_treatment_effect_ml_year float64	corticosteroid_flag int64	corticosteroid_dose_mg_day int64	immunosuppressant string	trial_drug_name string	trial_phase string	kl6_serum_u_ml int64	sp_d_serum_ng_ml float64	ca19_9_u_ml float64	mmp7_serum_ng_ml float64	cxcl13_pg_ml float64	telomere_length_kb float64	short_telomere_flag int64	lysophosphatidic_acid_um float64	ccl18_pg_ml float64	tnf_alpha_pg_ml float64	tgf_beta1_pg_ml float64	periostin_ng_ml float64	biomarker_trend_6m string	antigen_specific_igg_hp int64	ana_titer string	rheumatoid_factor_iu_ml float64	anti_ccp_flag int64	antigen_exposure_score float64	loinc_kl6 string	muc5b_rs35705950 string	tert_mutation_flag int64	terc_mutation_flag int64	sftpc_mutation_flag int64	abca3_mutation_flag int64	familial_ipf_flag int64	genetic_risk_score float64	wgs_available_flag int64	telomere_syndrome_flag int64	ae_ipf_flag int64	ae_count_total int64	ae_trigger string	ae_hospitalization_flag int64	ae_icu_admission_flag int64	ae_mechanical_ventilation_flag int64	ae_90day_mortality_probability float64	ae_steroid_response string	ae_methylprednisolone_dose_mg int64	ae_cyclophosphamide_flag int64	ae_time_to_first_months float64	post_ae_fvc_decline_ml float64	transplant_listed_flag int64	lung_allocation_score_baseline float64	lung_allocation_score_12m float64	waitlist_mortality_12m_flag int64	transplant_performed_flag int64	bilateral_transplant_flag int64	transplant_timing_months float64	clad_flag int64	survival_post_transplant_years float64	transplant_contraindication_flag int64	primary_annual_outcome string	all_cause_mortality_5yr_flag int64	respiratory_death_flag int64	overall_survival_months float64	hospitalization_any_5yr_flag int64	hospitalization_respiratory_5yr_flag int64	hospitalization_days_total int64	oxygen_requirement_progression string	dyspnea_mrc_score int64	st_george_qol_score float64	king_ild_score float64	ucsd_sobq_score float64	cci_comorbidity_index int64	pulmonary_hypertension_flag int64	emphysema_cpfe_flag int64	gerd_flag int64	obstructive_sleep_apnea_flag int64	cvd_comorbidity_flag int64
HC007-000001	CTD-ILD	72.2	Female	Black_Non-Hispanic	Former_Smoker	12.2	null	North_America	31.8	161.5	2,010	15	CB03.1Z	Indeterminate	17	0	0	7.9	0.7	Bilateral_Basal	23.5	0	1	5.55	15.1	GE	0.51	66.1	1.87	20	53.6	-5.17	53.6	0.401	0.822	366	88.9	92	0	0	Slow_Decliner	6	0	19876-2	19911-7	Untreated	0	0	3.4	0.739	0	0	null	null	0	1	58	null	null	null	521	32.1	18.8	8.72	712.2	6.07	0	2.035	174	3.44	15.16	11.06	Increasing	0	1:40-1:80	1.1	0	1.1	15088-0	TT_Wildtype	0	0	0	0	1	2.5	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	55.3	79.2	0	0	0	null	0	null	1	Progression	0	0	120	1	1	14	Exertional_to_Continuous	1	70.1	70.8	29.4	4	1	0	0	1	0
HC007-000002	IPF	67.9	Male	White_Non-Hispanic	Former_Smoker	34.5	Bird_Antigen	Other	20.2	180.6	2,012	24	CB03.10	UIP	36.9	0	0	7	2.2	Peripheral	14.1	0	0	4.17	35.2	Siemens	0.69	56.5	2.09	-213.1	69.2	-8.25	58.4	0.448	0.826	426	85.7	91.8	1	2.2	Stable	3	0	19876-2	19911-7	Untreated	0	0	2.9	0.777	0	0	null	null	0	0	0	Mycophenolate	null	null	1,172	51.5	10.8	9.68	258.4	3.96	1	2.183	612.3	20.05	44.18	19.09	Increasing	0	Negative	12.8	0	3.6	15088-0	TT_Wildtype	1	0	0	0	0	34.2	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	51	70	0	0	0	null	0	null	1	Death	0	0	42.4	0	1	0	Exertional_to_Continuous	4	77.7	77.4	27.3	4	0	1	1	1	1
HC007-000003	NSIP	70	Female	White_Non-Hispanic	Former_Smoker	40.5	Mold	Europe	22.5	165.4	2,012	49	CB03.11	Indeterminate	10.9	0	0	43	1.6	Bilateral_Basal	30.6	0	0	4.54	12.6	GE	1.19	102	2.5	-85.5	67.9	-0.89	55	0.322	0.904	394	87	93.7	0	0	Fast_Decliner	4	0	19876-2	19911-7	Untreated	0	0	2.5	0.893	0	0	null	null	0	0	0	null	null	null	1,103	81.5	58.7	6.99	618.7	6.11	0	2.226	536.5	8.09	11.75	16.41	Stable	0	Negative	8.4	0	2.6	15088-0	TT_Wildtype	0	1	0	0	0	21.3	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	32.7	48.7	0	0	0	null	0	null	1	AE	0	0	20.1	1	1	49	Stable	3	37	24.8	53.6	3	0	0	0	1	0
HC007-000004	CTD-ILD	54.3	Male	Other	Former_Smoker	21.7	Wood_Dust	North_America	29.2	178	2,010	60	CB03.1Z	Probable_UIP	9.1	0	0	3.5	0.6	Bilateral_Basal	49.5	0	1	3.15	8.3	GE	0.53	39.6	1.97	-128.1	38.1	-3.49	56.8	0.331	0.78	545	80.8	96.4	0	0	Slow_Decliner	4	22.2	19876-2	19911-7	Untreated	0	0	11.9	0.838	0	0	null	null	0	0	0	null	null	null	643	65	30.6	9.66	467	5.47	0	4.679	597.7	7.45	22.93	13.66	Increasing	0	Negative	10.5	0	2	15088-0	TG_Het	0	0	0	0	0	33.8	0	0	1	2	Drug_Reaction	1	0	0	0.609	Partial	500	0	25.8	-174.2	0	15	26.3	0	0	0	null	0	null	0	Death	1	1	92.8	1	0	18	Exertional_to_Continuous	1	53.2	95.7	18.4	5	0	0	0	0	1
HC007-000005	IPF	65.3	Male	White_Non-Hispanic	Former_Smoker	35.5	Wood_Dust	North_America	16.3	170.8	2,011	37	CB03.10	UIP	28.8	0	0	5.2	1.8	Bilateral_Basal	47.1	0	0	4.93	33.5	GE	1.1	93.1	3.35	-97	32.4	-1.29	91.8	0.42	0.774	243	83.6	95.5	1	2	Slow_Decliner	4	1.7	19876-2	19911-7	Pirfenidone	1,602	0	3.3	0.711	0	0	null	null	123.9	0	0	Azathioprine	null	null	714	32	14.4	18.46	417.4	5.73	0	2.403	489.4	10.96	8.33	40.36	Decreasing	0	Negative	26.3	0	2	15088-0	TG_Het	0	1	0	0	0	51.3	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	44.5	58.1	0	0	0	null	0	null	1	Death	1	0	7.1	1	1	53	Stable	2	42.9	41.5	34.3	4	0	0	1	0	1
HC007-000006	SR-ILD	53.6	Male	White_Non-Hispanic	Former_Smoker	6.2	null	North_America	27.3	172.9	2,018	39	CB03.13	Alternative_Dx	11.9	0	0	7.7	3.1	Bilateral_Basal	44.5	0	0	1.37	8.6	Philips	0.67	67.2	3.1	-67.2	29.5	-2.26	73.2	0.465	0.791	424	86.7	91.7	0	0	Slow_Decliner	3	0	19876-2	19911-7	Untreated	0	0	4.5	0.809	0	0	null	null	0	0	0	null	null	null	2,775	105.2	10.9	16.79	141.2	5.81	0	12.733	574.3	5.11	11.21	16.73	Stable	0	Negative	4.3	0	8.6	15088-0	TG_Het	0	0	0	0	0	28.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	29.5	31.6	0	0	0	null	0	null	0	Stable	1	1	41.1	0	0	0	None_to_Exertional	1	37.4	13.2	62.9	2	0	0	0	0	0
HC007-000007	CTD-ILD	60.2	Male	White_Non-Hispanic	Never	0	Asbestos	North_America	22.2	168.9	2,019	50	CB03.1Z	Alternative_Dx	25.1	0	0	13.4	1.6	Bilateral_Basal	22.7	0	0	1.66	26.8	GE	0.66	72.7	3.71	-80	90	-1.29	96.5	0.344	0.821	240	85.7	96	0	0	Stable	2	0	19876-2	19911-7	Untreated	0	0	0.5	0.76	0	0	null	null	0	1	58	null	null	null	498	127.3	6.9	14.57	353.3	4.15	1	5.368	333.3	12.09	14.53	12.37	Stable	1	1:40-1:80	5.8	0	2.9	15088-0	TT_Wildtype	0	0	0	0	0	20	0	1	0	0	null	0	0	0	0	null	0	0	null	null	0	48.1	51.6	0	0	0	null	0	null	1	AE	0	0	26.3	0	0	0	None_to_Exertional	1	35.8	25	48.5	3	0	0	0	1	0
HC007-000008	CTD-ILD	44.8	Male	White_Non-Hispanic	Former_Smoker	22.7	null	Europe	28	173.7	2,011	19	CB03.1Z	Probable_UIP	32.3	1	19.1	4.9	0.7	Bilateral_Basal	23.3	1	0	4.06	30.8	GE	1.57	67.9	2.62	-191.6	44.2	-4.63	71.2	0.306	0.723	424	87.5	91.1	0	0	Slow_Decliner	2	0.3	19876-2	19911-7	Untreated	0	0	1.1	0.887	0	0	null	null	0	0	0	Rituximab	null	null	318	56.2	6.5	17.81	415.3	8.27	0	8.751	608.1	12.54	15.61	38.09	Decreasing	0	Negative	2.4	0	6	15088-0	TT_Wildtype	0	0	0	0	0	9.7	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	61.1	84.2	0	0	0	null	0	null	0	Progression	0	0	120	1	0	67	Stable	0	21.1	43.8	17.9	2	0	0	0	0	1
HC007-000009	IPF	73.7	Female	Black_Non-Hispanic	Former_Smoker	71.6	null	Other	21.9	157	2,023	8	CB03.10	Probable_UIP	18.6	0	0	4.3	2.5	Bilateral_Basal	26.2	0	0	2.61	21.4	GE	2	74.3	2.42	-10.2	68.7	-6.24	76.1	0.361	0.864	167	80.1	92	1	4.1	Fast_Decliner	5	0	19876-2	19911-7	Trial_Drug	0	0	6	0.669	0	0	null	null	0	0	0	null	Placebo	Phase_II	321	107.5	51.3	9.18	2,393.7	5.6	0	4.503	993.5	8.21	14.74	45.86	Increasing	0	Negative	10.3	0	0.2	15088-0	TT_Wildtype	0	0	0	0	0	13.8	0	0	0	0	null	0	0	0	0	null	0	0	null	null	1	29.6	56.6	1	1	1	1	0	0.7	0	Progression	0	0	29.8	1	1	12	Stable	3	50.4	38.7	54.6	7	0	0	1	0	1
HC007-000010	IPF	77.9	Male	East_Asian	Former_Smoker	34.4	null	Europe	29.7	186.1	2,011	60	CB03.10	UIP	45.6	1	7.8	11.3	3.1	Bilateral_Basal	42.6	0	0	3.17	42	Philips	0.79	56.9	2.27	-181.3	41.5	-1.97	55.7	0.319	0.81	215	81.2	94.5	0	0	Stable	5	0	19876-2	19911-7	Untreated	0	0	1.8	0.662	0	0	null	null	0	0	0	Mycophenolate	null	null	1,278	225.3	47.1	6.13	241.9	5.34	0	9.923	315.2	9.25	15.8	27.63	Stable	1	Negative	10	0	1	15088-0	GG_Hom	1	0	0	0	1	62.6	0	0	1	1	Infection_Viral	1	0	0	0.682	null	1,000	0	16.5	-279.8	0	49.8	51.9	0	0	0	null	0	null	1	Progression	1	0	58.2	1	0	7	None_to_Exertional	2	32.3	31.2	55.4	2	0	1	0	1	1
HC007-000011	IPF	70.7	Female	East_Asian	Former_Smoker	53.5	Mold	Europe	27.6	161.8	2,019	60	CB03.10	UIP	53.6	1	6.1	6.4	2.2	Bilateral_Basal	37.7	1	0	2.86	59.7	Philips	0.84	89.1	3.01	-264.4	32.7	-3.24	65.6	0.404	0.871	208	90.9	90.5	0	0	Slow_Decliner	6	2.1	19876-2	19911-7	Pirfenidone	2,403	0	0.6	0.761	0	0	null	null	85.4	0	0	null	null	null	1,946	166.5	13.9	10.19	638.4	4.25	1	1.861	323.3	21.43	12.48	15.33	Increasing	0	1:160+	6	0	0.9	15088-0	TT_Wildtype	0	0	0	0	0	15.7	0	0	1	1	Drug_Reaction	1	0	0	0.437	null	1,000	0	23.6	-325.2	0	52.4	69.8	0	0	0	null	0	null	1	Stable	1	1	44.7	1	1	28	Exertional_to_Continuous	3	54.6	22.2	57.6	5	1	0	1	1	0
HC007-000012	COP	59.6	Male	White_Non-Hispanic	Former_Smoker	34	Wood_Dust	North_America	34.8	174.8	2,021	56	CB03.12	Alternative_Dx	10.5	0	0	46.4	1.5	Bilateral_Basal	13.6	0	0	5.83	10.2	Siemens	0.94	101.8	3.92	-135	58.3	-4.43	66.9	0.315	0.693	384	82.8	91.1	0	0	Improver	0	0	19876-2	19911-7	Untreated	0	0	6.2	0.777	0	0	null	null	0	1	52	Mycophenolate	null	null	270	57.7	66.2	10.6	295.5	5.83	0	5.875	693.2	11.31	27.52	21.35	Stable	0	Negative	20	0	0.8	15088-0	TT_Wildtype	0	0	0	0	0	33	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	46.1	46.9	0	0	0	null	0	null	0	Progression	0	0	5.9	1	0	38	Exertional_to_Continuous	2	35.6	18.9	15.4	2	0	0	0	1	1
HC007-000013	HP	65.4	Female	White_Non-Hispanic	Never	0	Mold	East_Asia	27.5	163.1	2,017	10	CA22	Probable_UIP	30.2	0	0	17.1	2.6	Bilateral_Basal	37.9	1	0	5.94	34.1	Siemens	1.68	56.3	1.71	-69.6	52.8	-2.01	76.7	0.438	0.871	394	83.6	98.7	0	0	Stable	5	0	19876-2	19911-7	Untreated	0	0	3.8	0.752	0	0	null	null	0	1	8	null	null	null	1,394	34.4	36.4	15.45	175.6	5.29	0	8.17	302.5	5.52	11.02	17.68	Increasing	1	Negative	2.4	0	0.3	15088-0	TG_Het	0	0	0	0	0	41.4	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	45.9	72.1	0	0	0	null	0	null	1	Progression	0	0	19.1	1	1	11	Stable	1	22.4	80	77.5	5	0	1	1	1	1
HC007-000014	CTD-ILD	51.3	Female	White_Non-Hispanic	Former_Smoker	24.5	null	East_Asia	23.5	160.6	2,016	33	CB03.1Z	Probable_UIP	26.2	0	0	6	0.3	Bilateral_Basal	48.4	0	0	1.89	20.6	Philips	1.26	86	3	1.5	70.8	-2.88	67.3	0.393	0.9	593	87.5	98.1	0	0	Stable	1	0	19876-2	19911-7	Untreated	0	0	4.4	0.902	0	0	null	null	0	0	0	null	null	null	636	76.6	26.1	14.24	722.4	4.83	0	8.593	269.5	11.88	22.15	23.93	Increasing	0	1:160+	9.5	0	2.3	15088-0	TT_Wildtype	0	0	0	0	0	13.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	17.1	30	0	0	0	null	0	null	0	Stable	0	0	23.2	1	0	12	Exertional_to_Continuous	3	31.2	54.1	39.1	2	0	0	0	1	0
HC007-000015	IPF	76.4	Female	White_Non-Hispanic	Former_Smoker	37.1	Wood_Dust	North_America	26.2	155.9	2,011	38	CB03.10	UIP	48.6	1	8.3	8	1.7	Diffuse	57.9	0	0	0	56.7	Philips	1.36	63.6	1.96	-146.6	63	-2.22	72.9	0.44	0.846	321	82.3	99	1	4.5	Fast_Decliner	5	0	19876-2	19911-7	Pirfenidone	2,403	0	0.5	0.785	0	1	Death	14.6	141.4	0	0	Mycophenolate	null	null	347	272.6	44.2	18.27	1,812.4	6.03	0	5	599.2	6.24	21.56	35.09	Stable	0	Negative	16.8	0	5.4	15088-0	TT_Wildtype	0	0	0	0	1	5.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	42.8	76	0	0	0	null	0	null	0	Progression	0	0	3	1	0	25	Stable	3	49.9	67	22.1	4	0	1	1	1	0
HC007-000016	IPF	48.7	Male	White_Non-Hispanic	Former_Smoker	40.7	null	Other	20.5	174.4	2,013	18	CB03.10	UIP	29.9	0	0	1.7	2.7	Bilateral_Basal	30	0	0	1.71	31.4	Siemens	1.32	70.9	2.49	-219	40.6	-5.54	72.4	0.235	0.822	403	92.5	95.4	0	0	Slow_Decliner	2	0	19876-2	19911-7	Nintedanib	0	300	7.1	0.808	1	1	Hepatotoxicity	22.3	191.7	0	0	Mycophenolate	null	null	1,859	148.8	36.4	4.03	418.1	5.14	0	2.167	329.9	5.66	11.26	24.23	Increasing	0	Negative	4.3	0	4	15088-0	TT_Wildtype	0	1	0	1	0	43.1	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	41.9	49.8	0	0	0	null	0	null	1	Stable	1	1	61.9	1	0	35	Exertional_to_Continuous	2	37.2	28.3	53.8	3	1	0	0	1	1
HC007-000017	HP	56	Female	White_Non-Hispanic	Former_Smoker	20.9	null	North_America	29.6	154.8	2,021	37	CA22	Probable_UIP	11.2	1	7.7	28.7	0.8	Bilateral_Basal	21.8	1	0	1.32	13.4	GE	1.91	101.5	3.52	-144.9	35	-1.54	63.8	0.275	0.872	375	80.7	95.9	0	0	Improver	3	0	19876-2	19911-7	Trial_Drug	0	0	1.3	0.652	0	0	null	null	0	1	35	null	GLPG1205	Phase_III	748	66.4	25.1	7.4	178.6	7.55	0	11.098	1,048.6	10.55	14.2	24.49	Increasing	1	1:160+	1.6	0	1.6	15088-0	TT_Wildtype	0	1	1	0	0	38.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	54.6	63.5	0	0	0	null	0	null	1	Transplant	0	0	87.6	0	1	0	Exertional_to_Continuous	3	26.7	39.1	69.2	4	1	0	0	0	0
HC007-000018	IPF	47.1	Female	White_Non-Hispanic	Former_Smoker	32.7	Wood_Dust	East_Asia	30.6	156.9	2,014	60	CB03.10	Indeterminate	25.9	1	13.1	3.8	1.8	Bilateral_Basal	29.3	1	0	4.95	19.1	Siemens	0.55	57.9	1.41	-100.8	30.8	-3.51	62.3	0.458	0.896	395	87	93.5	1	1.7	Stable	4	4.6	19876-2	19911-7	Pirfenidone	2,403	0	0.5	0.779	1	0	null	null	114.9	0	0	Mycophenolate	null	null	546	170.3	18.3	10.53	503.1	5.3	0	4.781	321.7	4.93	16.43	18.98	Decreasing	0	1:40-1:80	1.1	0	4.9	15088-0	TT_Wildtype	0	0	0	0	0	9.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	53.5	69.7	0	0	0	null	0	null	0	Stable	0	0	16.2	0	0	0	None_to_Exertional	2	72.3	26.7	67.5	3	0	1	0	1	0
HC007-000019	CTD-ILD	37.1	Female	White_Non-Hispanic	Former_Smoker	24	null	Other	40.3	166	2,010	23	CB03.1Z	UIP	10.3	0	0	15.9	0	Bilateral_Basal	31.3	0	1	5.13	5.1	Philips	0.74	90.7	2.84	-58.5	21.5	-1.33	58.6	0.337	0.851	374	83.3	92.9	1	1.2	Fast_Decliner	3	2.1	19876-2	19911-7	Untreated	0	0	10.2	0.787	0	0	null	null	0	1	38	null	null	null	1,172	134.5	20.4	14.01	424.7	6.66	0	5.037	251.3	8.36	32.14	34.21	Increasing	0	Negative	9.8	0	0.5	15088-0	TT_Wildtype	0	1	0	0	0	24.8	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	35.9	56.1	0	0	0	null	0	null	1	Progression	0	0	108.4	1	1	10	Stable	1	18.9	37.1	85.5	2	0	0	1	0	0
HC007-000020	HP	76.4	Female	East_Asian	Former_Smoker	76.4	Wood_Dust	Europe	24.3	149	2,020	25	CA22	Probable_UIP	29.5	0	0	12.8	0	Upper_Lobe	57.3	0	0	1.03	30.5	Siemens	1.07	82.2	2.72	-176.5	53.6	-1.56	83.2	0.292	0.856	464	87.8	96.6	0	0	Slow_Decliner	5	0	19876-2	19911-7	Trial_Drug	0	0	0.5	0.678	0	0	null	null	0	0	0	null	Pamrevlumab	Phase_III	1,735	21.3	6.1	31.41	2,428.1	6.62	0	22.909	444.4	11.44	14.19	29.49	Increasing	1	Negative	62.4	0	0.6	15088-0	TG_Het	0	0	0	0	0	51.6	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	19.2	38.7	0	0	0	null	0	null	0	Progression	0	0	15.6	1	0	69	Stable	2	66.8	68.3	35.5	3	0	0	0	0	0
HC007-000021	CTD-ILD	65.7	Female	White_Non-Hispanic	Former_Smoker	33.4	null	North_America	26.1	170.9	2,019	39	CB03.1Z	Indeterminate	12	0	0	4.5	1.4	Diffuse	23.3	0	0	1.62	20.1	Philips	1.23	70.5	2.22	-82.6	57.8	-2.13	63.8	0.368	0.919	260	84.5	98.1	0	0	Stable	4	0	19876-2	19911-7	Untreated	0	0	0.5	0.815	0	0	null	null	0	1	62	Mycophenolate	null	null	269	126.1	11.7	6.76	644.2	7.04	0	6.411	604.7	21.22	70.07	9.79	Increasing	0	Negative	3.9	0	0.4	15088-0	TG_Het	0	0	0	0	0	34.1	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	22.8	43.6	0	0	0	null	0	null	0	Transplant	0	0	31.9	1	1	22	None_to_Exertional	2	63.6	38.4	9.9	5	0	0	0	0	0
HC007-000022	IPF	59.8	Female	White_Non-Hispanic	Never	0	Bird_Antigen	Europe	24.5	166.4	2,010	23	CB03.10	UIP	33.8	0	0	6.2	2.8	Diffuse	51.1	0	0	0.09	39.8	Philips	0.67	76.6	3.14	-239.6	31.7	-3.72	72.6	0.395	0.866	97	86.9	96.4	0	0	Slow_Decliner	3	0	19876-2	19911-7	Trial_Drug	0	0	6.2	0.893	0	0	null	null	0	0	0	Rituximab	Placebo	Phase_II	1,474	71.6	93.7	7.73	142.6	4.62	0	4.431	557.9	11.24	22.36	10.07	Stable	0	1:40-1:80	14	0	2	15088-0	TT_Wildtype	0	0	0	0	0	18.6	0	0	1	1	Idiopathic	1	1	0	0.528	Complete	500	0	20.7	-231	0	58.9	70.1	0	0	0	null	0	null	0	AE	1	1	55.7	1	0	21	Exertional_to_Continuous	1	59.2	45	43.5	2	1	0	1	1	1
HC007-000023	SR-ILD	45	Male	East_Asian	Current	24.6	null	North_America	28.6	167.8	2,010	60	CB03.13	Probable_UIP	23.5	0	0	6.1	0.1	Bilateral_Basal	30.2	1	0	3.48	26.5	Philips	1.84	78.5	3.52	-97.3	37.8	-2.08	65.8	0.371	0.772	400	93.1	91.5	1	4.2	Slow_Decliner	1	1.5	19876-2	19911-7	Untreated	0	0	17.1	0.606	0	1	GI_Intolerance	13.1	0	1	5	null	null	null	692	39.6	11.5	8.92	1,040.3	7.76	0	4.275	650.2	3.92	18.87	20.78	Decreasing	0	Negative	0.4	0	2.4	15088-0	TT_Wildtype	0	0	0	0	0	13.4	0	1	0	0	null	0	0	0	0	null	0	0	null	null	0	41.1	62	0	0	0	null	0	null	0	Stable	0	0	23.6	1	1	15	None_to_Exertional	0	57	33.7	0	6	0	0	0	0	1
HC007-000024	NSIP	35	Male	East_Asian	Former_Smoker	39.7	null	East_Asia	29.5	169.7	2,011	18	CB03.11	UIP	5.6	0	0	38.8	0	Bilateral_Basal	37.3	0	0	3.11	1.5	Canon	1.52	53.1	2.17	-75.8	57.7	-1.28	82.9	0.408	0.896	189	83.6	95.2	0	0	Stable	2	0	19876-2	19911-7	Untreated	0	0	0.7	0.845	0	0	null	null	0	0	0	null	null	null	572	70.4	5.1	7.59	663.7	4.85	0	8.909	302.7	4.23	23.42	39.86	Decreasing	0	1:160+	12.8	0	0.1	15088-0	TT_Wildtype	0	0	0	0	0	14.5	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	24.6	55.4	0	0	0	null	0	null	1	Progression	0	0	32.7	0	0	0	Exertional_to_Continuous	4	29.4	62.6	30.3	2	0	0	1	0	1
HC007-000025	CTD-ILD	48.5	Female	Hispanic	Former_Smoker	11.2	null	North_America	27.2	160.9	2,010	34	CB03.1Z	Indeterminate	8.6	0	0	4	2.7	Bilateral_Basal	35.4	0	0	4.86	3.9	GE	1.9	63.1	2.14	-91.5	47.9	-2.29	40.2	0.4	0.813	485	83.5	91.7	0	0	Stable	3	0	19876-2	19911-7	Untreated	0	0	1.9	0.881	0	1	Hepatotoxicity	1.7	0	0	0	Mycophenolate	null	null	418	85.5	45.7	7.07	766.5	6.56	0	3.697	987.2	19.36	8.27	43.96	Stable	0	Negative	2.2	0	0.1	15088-0	TT_Wildtype	1	0	0	0	0	36.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	26.1	45.5	0	0	0	null	0	null	0	Progression	0	0	60.4	0	1	0	None_to_Exertional	3	33.4	35.8	43.3	4	0	1	1	1	0
HC007-000026	IPF	90	Male	White_Non-Hispanic	Never	0	Wood_Dust	Europe	33.1	177	2,018	53	CB03.10	UIP	35.1	0	0	5.9	2.6	Diffuse	66.4	0	0	4.24	40	Philips	1.91	51.2	2.21	-110.6	46.6	-3.09	72.2	0.397	0.822	278	85.4	93	0	0	Stable	6	10.6	19876-2	19911-7	Pirfenidone	2,403	0	4.3	0.885	0	0	null	null	84.4	0	0	null	null	null	1,082	41.4	27.1	11.28	492.9	4.11	1	8.224	139.9	5.95	26.28	35.93	Stable	0	Negative	5.1	0	1.1	15088-0	TG_Het	0	0	1	0	0	56.4	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	44.8	51.3	0	0	0	null	0	null	0	Death	0	0	14	1	0	26	Stable	3	77.9	72.5	39.2	3	0	0	1	1	1
HC007-000027	IPF	71.3	Male	Hispanic	Former_Smoker	38.8	null	Other	24.3	171.1	2,011	9	CB03.10	Probable_UIP	46.9	1	10.1	2.1	2.6	Bilateral_Basal	39	0	0	4.48	55.1	Philips	1.27	65	2.74	-298.4	44.1	-2.08	50.4	0.461	0.826	231	94.4	98.9	1	2	Slow_Decliner	5	16.3	19876-2	19911-7	Pirfenidone	2,403	0	2.2	0.671	0	0	null	null	81.6	0	0	Mycophenolate	null	null	2,315	62.1	28.3	18.03	818.5	5.63	0	11.714	258.1	3.83	9.69	22.75	Decreasing	1	Negative	9	0	0.1	15088-0	TG_Het	0	0	0	0	0	35.4	0	1	1	1	Idiopathic	1	0	0	0.544	null	750	0	10.7	-364.5	1	43.5	59.9	0	1	1	1	1	0.59	0	Progression	1	1	49	1	1	12	Exertional_to_Continuous	3	62.3	40.2	65.2	5	0	0	1	1	0
HC007-000028	IPF	61.4	Female	White_Non-Hispanic	Never	0	Mold	North_America	32.6	155.2	2,018	25	CB03.10	UIP	28.2	1	13.7	7.2	1.6	Bilateral_Basal	18.8	0	0	0	32.1	Philips	1.78	94.2	2.99	-194.5	54	-4.55	73.5	0.379	0.878	587	86.6	90.4	0	0	Stable	3	0	19876-2	19911-7	Nintedanib	0	300	16.6	0.773	1	1	Progression	19.4	159.8	0	0	null	null	null	1,598	54.7	19.6	11.7	491.1	7.05	0	5.737	458	4.94	23.29	51.03	Stable	0	Negative	1.1	0	3.8	15088-0	TT_Wildtype	0	0	0	0	0	3.7	1	0	1	1	Infection_Viral	1	0	0	0.78	null	1,000	0	9.2	-96.3	0	61.9	59.2	0	0	0	null	0	null	1	AE	1	1	53.6	1	0	20	Exertional_to_Continuous	2	52.4	96.5	51.4	5	0	0	0	1	0
HC007-000029	IPF	71.7	Female	White_Non-Hispanic	Former_Smoker	39	null	North_America	30.3	165.4	2,012	22	CB03.10	UIP	59.7	1	2.8	6.8	1.9	Bilateral_Basal	38.4	0	0	1.88	74.2	GE	1.61	80.5	2.37	-277.2	41	-0.47	65.9	0.377	0.925	328	93.2	99	1	3.5	Stable	5	4.4	19876-2	19911-7	Pirfenidone	1,602	0	18	0.779	1	0	null	null	88.1	0	0	Azathioprine	null	null	311	107.5	46	7.17	262.7	6.58	0	10.943	273.7	12.15	12.97	17.09	Decreasing	0	1:160+	200	0	1.8	15088-0	TT_Wildtype	0	0	0	0	0	18.2	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	41	59.6	0	0	0	null	0	null	0	AE	1	1	20.4	1	1	40	None_to_Exertional	2	33.1	72	63.6	3	0	0	1	1	1
HC007-000030	CTD-ILD	36.3	Male	White_Non-Hispanic	Current	22	Asbestos	Europe	27.4	171.7	2,023	20	CB03.1Z	Probable_UIP	13.4	1	3.7	3.2	2.6	Diffuse	32.1	0	1	5.19	11.3	Siemens	1.04	48.2	2.09	-33.5	50.2	-6.86	47.3	0.428	0.821	340	86.1	95.6	1	3.3	Slow_Decliner	3	5	19876-2	19911-7	Untreated	0	0	0.5	0.854	0	0	null	null	0	1	41	Mycophenolate	null	null	134	55.7	75.5	9.99	372.7	7.98	0	5.805	359	8.64	11.94	20.69	Increasing	0	Negative	3.9	0	0.7	15088-0	TT_Wildtype	0	1	0	0	0	29.1	1	0	1	1	Idiopathic	1	0	0	0.571	Partial	500	0	54.4	-113.3	0	46.6	46.3	0	0	0	null	0	null	0	AE	0	0	38	1	0	26	None_to_Exertional	2	27.5	47	59.3	0	0	0	0	1	1
HC007-000031	CTD-ILD	51.4	Female	White_Non-Hispanic	Current	31.8	Mold	North_America	25.9	172.3	2,020	17	CB03.1Z	Probable_UIP	8.5	0	0	5.4	0.3	Bilateral_Basal	29.2	0	0	2.07	10.2	Canon	1.49	69.1	1.99	-115.7	27.9	-3.43	72.7	0.413	0.924	431	92.9	92.6	0	0	Fast_Decliner	4	0	19876-2	19911-7	Untreated	0	0	3	0.901	0	0	null	null	0	0	0	Rituximab	null	null	164	24	14.6	6.56	297.6	6.08	0	4.005	224.3	11.29	33.41	12.06	Stable	0	1:40-1:80	16.9	0	0.9	15088-0	TT_Wildtype	0	0	0	0	0	18	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	41.5	60.2	0	0	0	null	0	null	0	Stable	0	0	44	0	0	0	Exertional_to_Continuous	3	22.5	49.4	13.4	5	1	0	0	0	0
HC007-000032	SR-ILD	64.2	Male	White_Non-Hispanic	Former_Smoker	64.3	Metal_Dust	North_America	40.1	172.3	2,015	6	CB03.13	Probable_UIP	11.5	1	5.5	12.1	0.2	Bilateral_Basal	28.2	1	0	0	4.2	Siemens	1.93	78.2	2.72	-117	57.2	-4.31	71.1	0.326	0.83	437	89	94.2	0	0	Improver	1	0	19876-2	19911-7	Untreated	0	0	8.4	0.77	1	0	null	null	0	0	0	Mycophenolate	null	null	232	51	36.8	18.02	449.1	7.77	0	2.228	385.4	8.03	15.8	20.64	Increasing	0	Negative	49	0	1.5	15088-0	TG_Het	0	0	0	0	0	32.3	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	51.8	64.5	0	0	0	null	0	null	0	Stable	1	1	28.5	0	0	0	None_to_Exertional	3	30.9	75.4	67.6	4	0	0	0	0	1
HC007-000033	IPF	66.1	Male	White_Non-Hispanic	Former_Smoker	33.9	Mold	North_America	23.3	177.7	2,016	42	CB03.10	UIP	41.6	0	0	3	1.1	Upper_Lobe	37.9	0	0	4.9	46.8	Canon	1.65	83.4	3.84	-60.7	51.4	-4.78	64.8	0.374	0.904	438	89.8	91.9	1	3.9	Stable	3	5.1	19876-2	19911-7	Pirfenidone	2,403	0	1.4	0.89	0	0	null	null	131.6	0	0	Rituximab	null	null	707	37.8	54.3	23	354.8	4.83	0	7.135	616.6	4.7	8.91	15.94	Stable	0	Negative	11.6	0	0.1	15088-0	TT_Wildtype	0	0	0	0	0	10.7	0	0	1	1	Idiopathic	1	0	0	0.509	null	1,000	0	28.4	-133.8	0	63.1	84.1	0	0	0	null	0	null	0	Progression	1	1	22.5	1	1	23	None_to_Exertional	2	38.6	54.5	38	3	1	0	0	0	1
HC007-000034	IPF	74.9	Female	East_Asian	Former_Smoker	78	Metal_Dust	North_America	29	159.9	2,010	3	CB03.10	UIP	32.4	1	5	9	2.3	Bilateral_Basal	50.8	0	0	1.99	43	Siemens	1.56	58.3	1.64	-274.8	47.2	-2.89	66.5	0.406	0.832	203	79.8	92.4	0	0	Improver	6	17.8	19876-2	19911-7	Nintedanib	0	300	0.7	0.573	0	0	null	null	78.9	1	41	Azathioprine	null	null	874	30.7	14	4.97	248.9	5.16	0	7.226	306.5	3.34	24.29	52.93	Decreasing	0	Negative	1.9	0	3.9	15088-0	TT_Wildtype	0	0	0	0	0	22.2	0	0	1	1	Procedure	1	0	0	0.387	Partial	1,000	0	11.9	-164.4	1	53.3	66.7	0	1	0	3.4	1	8.1	0	Progression	1	0	71	1	0	1	Stable	2	46.5	60	57.6	3	0	0	1	0	1
HC007-000035	IPF	70.4	Female	White_Non-Hispanic	Former_Smoker	26.3	null	Europe	23.6	158.7	2,010	60	CB03.10	Probable_UIP	34.2	0	0	7.7	2.8	Peripheral	25.6	0	0	5.43	32.4	GE	0.83	47.7	1.52	-218.9	80.6	-5.75	70.3	0.345	0.79	381	79.1	94.2	0	0	Fast_Decliner	6	0	19876-2	19911-7	Pirfenidone	2,403	0	1	0.947	0	1	GI_Intolerance	22.2	42.1	0	0	null	null	null	1,146	135.4	74.3	12.36	280.5	5.98	0	10.9	241	5.38	10.09	47.97	Stable	0	Negative	9.2	0	0.8	15088-0	TT_Wildtype	1	0	0	0	0	54.9	0	0	1	1	Idiopathic	1	0	0	0.661	null	500	0	12.6	-351.2	0	65.7	90	0	0	0	null	0	null	0	Progression	0	0	8.7	1	1	38	Exertional_to_Continuous	3	65.2	90.3	64	4	0	0	0	0	0
HC007-000036	IPF	73.7	Male	White_Non-Hispanic	Former_Smoker	21.2	Bird_Antigen	Europe	36.8	182.9	2,017	14	CB03.10	UIP	38.1	0	0	15.5	2.1	Bilateral_Basal	26.4	0	0	3.16	46.1	Canon	1.75	69	2.67	-121.9	52.6	0.8	84.5	0.348	0.935	302	92.4	93	1	3.4	Improver	5	0	19876-2	19911-7	Nintedanib	0	300	1.9	0.737	1	0	null	null	167.2	0	0	null	null	null	1,172	108	54.2	7.47	329.2	6.99	0	10.288	322.9	8.68	28.34	25.32	Stable	0	1:160+	0.9	0	0.3	15088-0	TG_Het	0	0	0	0	0	20.1	0	0	0	0	null	0	0	0	0	null	0	0	null	null	1	48.5	66.1	0	1	1	4.7	1	12.02	0	Progression	0	0	41.6	1	0	15	None_to_Exertional	2	82	52.1	31.3	0	1	0	0	0	0
HC007-000037	IPF	60.1	Female	White_Non-Hispanic	Current	20.5	null	North_America	32.1	159.3	2,010	12	CB03.10	UIP	39.3	0	0	6.4	4	Upper_Lobe	44.6	0	0	2.62	50.4	Philips	1.08	80.2	2.27	-133.9	47.5	-6.2	63.6	0.297	0.785	243	92.3	91.2	0	0	Slow_Decliner	3	8.4	19876-2	19911-7	Pirfenidone	2,403	0	6.2	0.869	0	1	Death	28.7	128.9	0	0	null	null	null	1,160	37.3	8.2	11.38	66.5	5.03	0	20.914	965.6	4.52	16.34	30.98	Increasing	0	Negative	5.5	0	0.9	15088-0	TT_Wildtype	0	0	0	0	0	15.7	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	23	44.8	0	0	0	null	0	null	0	Progression	1	1	59.6	1	0	14	Stable	1	70.6	6	34	4	0	0	0	1	1
HC007-000038	IPF	76	Male	White_Non-Hispanic	Former_Smoker	77	Asbestos	Europe	24	171.4	2,018	14	CB03.10	Probable_UIP	48.4	0	0	1.9	1.4	Upper_Lobe	46	0	0	6.06	49.8	GE	1.44	74.2	2.8	-260.2	58	-5.4	82.2	0.22	0.781	335	98	93.3	1	2.3	Slow_Decliner	4	0	19876-2	19911-7	Untreated	0	0	0.5	0.657	0	0	null	null	0	0	0	Mycophenolate	null	null	2,672	31.1	79.5	10.56	830.5	6.77	0	4.269	960	13.35	9.88	18.14	Increasing	0	Negative	61.1	0	3	15088-0	TT_Wildtype	0	0	0	0	0	10.7	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	32.1	42	0	0	0	null	0	null	0	Transplant	0	0	70	1	1	32	Exertional_to_Continuous	3	20.8	51.5	52.9	4	0	1	1	0	0
HC007-000039	IPF	83.3	Male	White_Non-Hispanic	Former_Smoker	49.8	null	North_America	30.2	170	2,015	60	CB03.10	UIP	36.6	1	6.7	11.5	2.5	Bilateral_Basal	46.9	1	0	0.46	42.6	Siemens	1.52	54.1	2.56	-59.3	83.8	-5.59	67.5	0.358	0.745	158	79.6	90.1	1	6	Fast_Decliner	5	0	19876-2	19911-7	Nintedanib	0	300	0.7	0.976	0	0	null	null	159.9	0	0	null	null	null	371	62.7	8.6	5.64	451.8	6.12	0	7.49	319	4.95	22.84	6.9	Decreasing	0	Negative	1.5	1	0.3	15088-0	TT_Wildtype	0	0	0	0	0	7.7	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	51.9	61.4	0	0	0	null	0	null	0	Stable	1	0	8.5	0	0	0	Exertional_to_Continuous	1	29.9	71.5	39.5	4	1	0	1	0	1
HC007-000040	HP	48.4	Male	White_Non-Hispanic	Never	0	null	North_America	28.8	176.2	2,011	15	CA22	Alternative_Dx	12.2	1	4	20.7	0.9	Diffuse	26.8	0	0	6.21	21.3	Siemens	1.27	105.6	4.79	-62.5	62	-3.1	86.1	0.388	0.896	448	89.4	90.2	1	1.1	Slow_Decliner	0	0	19876-2	19911-7	Untreated	0	0	3.2	0.856	0	0	null	null	0	1	33	null	null	null	1,137	30.1	12.8	20.17	190.5	6.97	0	4.005	636.4	3.58	20.26	16.76	Increasing	1	Negative	3	0	0.3	15088-0	TG_Het	0	0	0	0	0	17.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	39.1	40.9	0	0	0	null	0	null	1	Stable	0	0	86.6	1	0	8	Stable	1	26.4	54.3	96.7	3	1	0	1	0	1
HC007-000041	IPF	58.1	Male	White_Non-Hispanic	Former_Smoker	57.5	Metal_Dust	Europe	24.8	179.5	2,017	28	CB03.10	Indeterminate	31.8	0	0	9.6	3	Bilateral_Basal	42.3	0	0	1.86	36.1	Siemens	0.75	68.2	2.87	-121	18	-1.47	64.7	0.314	0.91	302	81.9	90.2	1	5	Fast_Decliner	3	14.7	19876-2	19911-7	Pirfenidone	1,602	0	4.7	0.814	0	1	GI_Intolerance	20.4	69.5	0	0	Mycophenolate	null	null	1,511	57.7	38.4	10.22	562.3	4.6	0	10.57	440.2	8.17	7.03	35.66	Increasing	0	Negative	75.5	0	2	15088-0	TG_Het	0	0	0	0	0	37.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	42	45.9	0	0	0	null	0	null	0	Stable	1	1	19.6	1	0	40	None_to_Exertional	2	63.4	24.8	52.3	5	0	0	1	0	0
HC007-000042	NSIP	79	Female	East_Asian	Former_Smoker	47.4	null	North_America	31.4	168.2	2,017	4	CB03.11	Alternative_Dx	4.2	1	3.3	29.9	0.6	Bilateral_Basal	45.3	0	0	3.54	8.6	GE	1.55	77.5	2.24	-156.6	64.9	-2.45	58.7	0.463	0.842	315	83.3	99	0	0	Fast_Decliner	4	0	19876-2	19911-7	Untreated	0	0	0.5	0.385	0	0	null	null	0	0	0	null	null	null	248	69.6	51.1	8.71	209.1	5.96	0	3.469	1,095.4	11.95	16.03	30.54	Increasing	0	1:160+	6.6	0	0.8	15088-0	TT_Wildtype	1	0	0	0	0	36.1	0	1	0	0	null	0	0	0	0	null	0	0	null	null	0	32.3	46.1	0	0	0	null	0	null	0	Progression	0	0	110.9	1	1	11	None_to_Exertional	3	57.9	46.3	21.8	0	0	1	0	0	0
HC007-000043	CTD-ILD	52.7	Male	Black_Non-Hispanic	Current	34.1	null	Europe	29.5	169.3	2,020	60	CB03.1Z	Probable_UIP	25.6	0	0	3.6	1	Bilateral_Basal	31.3	0	0	3.56	19.3	GE	0.87	62.1	2.1	-78.5	43.9	-0.56	52.6	0.317	0.761	347	84.5	95.2	0	0	Slow_Decliner	2	2.7	19876-2	19911-7	Untreated	0	0	7.7	0.659	0	0	null	null	0	0	0	Azathioprine	null	null	872	80.1	24	11.68	209.1	6.37	0	10.467	509.8	17.22	18.53	20.17	Stable	0	1:40-1:80	2.8	0	0.1	15088-0	TT_Wildtype	0	0	0	0	0	10.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	59.3	72.8	0	0	0	null	0	null	0	Progression	0	0	9.7	1	0	14	None_to_Exertional	2	35	77.7	106.2	6	0	1	0	1	0
HC007-000044	IPF	81	Male	White_Non-Hispanic	Former_Smoker	7.1	null	Other	28.6	179.7	2,012	60	CB03.10	UIP	56.9	1	8	15.7	2.1	Bilateral_Basal	48.9	0	0	2.3	65.6	Siemens	0.9	89.9	4.01	-127.8	19.2	-5.15	67.5	0.435	0.82	314	88.9	95.8	1	2.4	Slow_Decliner	5	5.7	19876-2	19911-7	Nintedanib	0	300	0.6	0.863	0	0	null	null	170.2	0	0	Azathioprine	null	null	1,558	81.8	13.4	7.13	462.7	6.27	0	3.889	387.2	3.65	18.11	35.51	Stable	0	1:40-1:80	13	0	5.8	15088-0	TT_Wildtype	0	0	0	0	0	24.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	60.4	76.6	0	0	0	null	0	null	0	Progression	0	0	7.8	1	0	39	None_to_Exertional	1	42	19.6	61.1	4	0	0	0	1	0
HC007-000045	NSIP	57.7	Male	White_Non-Hispanic	Former_Smoker	30.2	Metal_Dust	Europe	27.3	176.6	2,017	3	CB03.11	Alternative_Dx	21.3	0	0	40.5	0.6	Bilateral_Basal	36.5	0	0	1.6	26	GE	0.69	84.3	3.34	-78.9	85.2	-2.18	56.9	0.405	0.802	468	83.7	94	1	2.7	Slow_Decliner	0	0	19876-2	19911-7	Pirfenidone	1,602	0	7.8	0.683	0	0	null	null	130.9	0	0	Azathioprine	null	null	582	41.7	18	10.06	1,197	5.37	0	9.582	1,366.4	16.64	15.27	19.39	Increasing	0	Negative	4.7	0	3.4	15088-0	TT_Wildtype	0	0	0	0	0	11.5	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	39.3	46.8	0	0	0	null	0	null	0	Progression	1	1	51.2	0	1	0	Stable	4	48.1	13.6	51	3	0	0	1	0	0
HC007-000046	CTD-ILD	72.5	Male	Hispanic	Former_Smoker	26.7	Wood_Dust	Europe	29.7	161.3	2,021	13	CB03.1Z	Indeterminate	7.8	1	13.5	21.8	1	Bilateral_Basal	26.6	0	0	2.42	1.9	Canon	1.43	79.7	3.01	-142.2	81.7	-4.11	87.7	0.511	0.758	256	87.2	95.5	1	0.5	Fast_Decliner	3	0	19876-2	19911-7	Nintedanib	0	300	4.2	0.861	0	0	null	null	60.2	0	0	Rituximab	null	null	110	69.6	16.4	4.4	424.9	4.69	0	12.477	233.5	8.96	22.15	13.86	Stable	0	Negative	0.3	0	10	15088-0	TT_Wildtype	1	0	0	0	0	36.1	0	0	1	1	Idiopathic	1	1	0	0.571	null	1,000	0	24.3	-321	0	39.4	53.8	0	0	0	null	0	null	0	Progression	0	0	87.1	1	1	32	Stable	2	54.1	31.3	91.5	5	0	0	0	1	0
HC007-000047	IPF	68.3	Female	Other	Current	40.3	null	North_America	28.7	171.9	2,013	6	CB03.10	Probable_UIP	26.5	0	0	4.9	1.4	Peripheral	54.9	0	0	1.07	24.3	Philips	0.68	49.3	1.54	-164.3	35.5	-3.04	55.8	0.412	0.791	294	91.2	97.5	1	2	Fast_Decliner	6	0	19876-2	19911-7	Pirfenidone	1,602	0	2.4	0.753	1	0	null	null	91.2	0	0	Azathioprine	null	null	2,356	143.8	43.5	3.39	164.3	2.81	1	2.381	557.5	5.99	20.65	35.51	Stable	0	1:160+	1.6	0	2.7	15088-0	TT_Wildtype	1	0	0	0	0	29.3	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	57.3	81.1	0	0	0	null	0	null	0	Stable	0	0	97.2	0	1	0	None_to_Exertional	3	66.6	70.9	60	6	1	0	0	1	1
HC007-000048	IPF	69.6	Male	White_Non-Hispanic	Former_Smoker	54.1	Mold	North_America	27.8	163.5	2,021	60	CB03.10	UIP	33.6	1	3.1	7.7	2.4	Upper_Lobe	20.4	0	0	7.32	40	GE	1.02	89.7	3.67	13.4	35.6	-1.28	58.3	0.293	0.85	309	92.6	95.2	1	1.1	Fast_Decliner	3	0	19876-2	19911-7	Pirfenidone	2,403	0	0.5	0.667	0	1	Progression	1	57.6	0	0	null	null	null	1,406	20	16	6.79	240.7	6.84	0	2.696	1,160.1	11.48	16.65	18.07	Stable	0	Negative	96.4	0	5	15088-0	TG_Het	1	0	0	0	0	52.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	1	54.6	71.1	0	0	0	null	0	null	0	Progression	1	1	4.4	1	1	17	Stable	2	48	7	49.9	4	0	0	0	1	0
HC007-000049	CTD-ILD	73.8	Female	Black_Non-Hispanic	Former_Smoker	30.1	null	North_America	24.2	167.6	2,020	8	CB03.1Z	UIP	9.1	0	0	7	0.2	Bilateral_Basal	41.1	1	0	2.19	8.5	Canon	1.83	87.6	2.26	-93.9	60.6	-6.88	76.1	0.443	0.784	259	90.5	98.9	1	2.2	Stable	4	0	19876-2	19911-7	Untreated	0	0	4.1	0.58	0	0	null	null	0	0	0	Mycophenolate	null	null	796	81.1	13.2	8.45	709.2	7.82	0	6.965	710.7	16.08	14.96	40.99	Increasing	0	1:40-1:80	12.1	0	2.8	15088-0	TT_Wildtype	0	0	0	0	0	26.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	22.4	35.7	0	0	0	null	0	null	0	AE	0	0	23.5	0	1	0	Stable	1	40.5	50.4	10.4	2	0	0	1	1	0
HC007-000050	IPF	63.4	Female	Black_Non-Hispanic	Former_Smoker	48.3	Mold	East_Asia	36.3	175.4	2,016	49	CB03.10	UIP	45.7	1	6.9	6.6	3.3	Bilateral_Basal	48.8	0	0	5.63	55.8	GE	1.18	88.3	2.32	-132.9	35.8	0.48	84.6	0.482	0.838	345	89.3	93.9	1	0.5	Improver	3	0	19876-2	19911-7	Pirfenidone	2,403	0	1.6	0.6	0	0	null	null	103.3	0	0	Mycophenolate	null	null	112	32.9	6.8	4.58	475.3	2.99	1	6.534	261.4	3.53	17.45	9.04	Increasing	0	1:40-1:80	47.3	0	0.7	15088-0	TT_Wildtype	0	0	0	0	0	19.9	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	50.2	65.5	0	0	0	null	0	null	1	Progression	1	1	4.8	1	0	19	None_to_Exertional	2	51.7	57.9	0	1	0	0	0	1	0
HC007-000051	IPF	57.6	Male	East_Asian	Former_Smoker	77.5	null	East_Asia	22	177.2	2,022	56	CB03.10	UIP	46.1	0	0	3.2	2.3	Bilateral_Basal	28.4	0	0	5.36	52.3	Siemens	1.84	70.7	3.07	-81.4	47.8	-3.79	78.2	0.274	0.713	261	86.3	95.8	1	0.5	Slow_Decliner	2	0	19876-2	19911-7	Trial_Drug	0	0	1	0.619	0	0	null	null	0	0	0	Mycophenolate	BLU-5937	Phase_II	827	154.8	13.8	8.6	783.3	5.91	0	5.077	251.7	6.58	12.92	18.45	Increasing	0	1:160+	2.4	0	9.8	15088-0	TT_Wildtype	0	0	0	0	0	25.3	0	0	1	1	Infection_Viral	1	0	0	0.537	Partial	500	1	3	-55.9	0	47.9	70.9	0	0	0	null	0	null	0	Stable	0	0	33.6	0	0	0	Exertional_to_Continuous	2	40.5	48	83.7	0	0	0	0	1	1
HC007-000052	IPF	62.5	Female	White_Non-Hispanic	Current	42.5	Asbestos	North_America	29.7	155.1	2,023	60	CB03.10	UIP	34.2	0	0	3.3	3.2	Bilateral_Basal	26.5	0	1	3.96	37.9	GE	1.24	68.7	1.93	-32.5	38.6	-6.71	82.8	0.418	0.921	197	84.2	96.1	1	2.5	Stable	4	9.3	19876-2	19911-7	Nintedanib	0	300	16	0.928	0	0	null	null	141.9	0	0	Rituximab	null	null	440	108.9	20.2	8.44	470.6	5.27	0	4.546	166.3	6.22	10.92	33.07	Increasing	0	Negative	7.6	0	6.5	15088-0	TT_Wildtype	0	0	0	0	1	8.3	0	0	0	0	null	0	0	0	0	null	0	0	null	null	1	44.2	58.6	0	0	0	null	0	null	0	Stable	0	0	14.3	0	1	0	Exertional_to_Continuous	2	51.5	18.4	59.8	6	0	0	1	1	0
HC007-000053	CTD-ILD	60.4	Female	White_Non-Hispanic	Former_Smoker	27.4	Asbestos	North_America	25.8	156.9	2,013	16	CB03.1Z	Alternative_Dx	3	0	0	9.3	0	Upper_Lobe	29.7	0	0	2.92	2.4	Canon	0.77	70.7	2.34	-78.4	51.6	-4.89	66.9	0.432	0.797	410	89.7	91.2	0	0	Stable	4	0	19876-2	19911-7	Untreated	0	0	4.3	0.536	0	0	null	null	0	1	15	Mycophenolate	null	null	1,484	106.8	9	10.69	661	8.2	0	3.621	1,259	11.17	10.49	31.4	Increasing	1	1:160+	6.7	0	0.2	15088-0	TT_Wildtype	0	0	0	0	0	17.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	31.5	40.3	0	0	0	null	0	null	0	Progression	1	1	5.1	0	0	0	None_to_Exertional	2	40.9	50.6	46.8	2	0	0	0	0	1
HC007-000054	HP	41.2	Female	White_Non-Hispanic	Current	31.7	null	North_America	36.6	160.2	2,023	4	CA22	UIP	25.7	0	0	22.7	2.3	Peripheral	53.9	0	0	3.61	29.7	Siemens	1.64	112	3.52	-125.1	35.5	-3.3	67.1	0.367	0.872	507	81.7	94.1	0	0	Stable	2	0	19876-2	19911-7	Untreated	0	0	1.4	0.878	0	0	null	null	0	1	28	Mycophenolate	null	null	415	40	5.5	14.99	2,021.7	6.21	0	7.379	201.7	16.95	15.8	21.96	Decreasing	1	Negative	4.2	0	1.9	15088-0	TG_Het	0	0	0	0	0	43.4	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	31.7	40.6	0	0	0	null	0	null	1	Stable	0	0	52.9	0	1	0	Exertional_to_Continuous	2	65.7	26.2	48.3	4	0	0	0	0	1
HC007-000055	CTD-ILD	62.6	Female	White_Non-Hispanic	Former_Smoker	52.8	null	Europe	22.8	145.5	2,010	3	CB03.1Z	Indeterminate	14.4	0	0	6.1	1.3	Bilateral_Basal	28.2	0	0	4.4	19.9	Siemens	1.03	64.2	2.3	-140	71.2	-4.89	96.2	0.235	0.831	365	87.6	88.5	0	0	Slow_Decliner	3	0	19876-2	19911-7	Nintedanib	0	300	0.7	0.544	0	0	null	null	174.9	0	0	Azathioprine	null	null	1,690	78.1	48.6	25.95	97.8	7.26	0	3.392	734.6	8.47	11.67	28.32	Decreasing	0	Negative	10.5	0	0.3	15088-0	TT_Wildtype	0	0	0	0	0	19.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	15	23.6	0	0	0	null	0	null	1	Transplant	0	0	78.8	1	0	15	None_to_Exertional	1	67.3	50.9	60	1	1	0	0	1	0
HC007-000056	CTD-ILD	48.5	Female	White_Non-Hispanic	Former_Smoker	24.8	null	Europe	23.7	160.5	2,011	33	CB03.1Z	Alternative_Dx	12.4	0	0	7.7	0.8	Bilateral_Basal	42.1	0	0	3.41	16.3	Canon	1.95	52.6	1.38	-140.6	77.3	-7.6	91.7	0.362	0.844	350	81.6	93.6	0	0	Stable	3	0	19876-2	19911-7	Trial_Drug	0	0	1.5	0.601	0	0	null	null	0	1	11	null	GLPG1205	Phase_II	1,169	83.5	10	13.66	2,882.5	5.9	0	7.536	164.3	7.06	15.43	26.31	Increasing	0	1:40-1:80	2.1	0	2	15088-0	TT_Wildtype	0	0	0	0	0	27.6	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	34.1	42.5	0	0	0	null	0	null	0	Stable	1	1	49.8	0	0	0	Exertional_to_Continuous	3	40.7	30.2	68.5	5	0	0	0	1	1
HC007-000057	IPF	78.5	Female	White_Non-Hispanic	Never	0	null	Europe	22.5	158.2	2,010	43	CB03.10	UIP	38.1	1	1.4	12.2	1.3	Bilateral_Basal	43.6	0	0	0	39.8	Philips	0.89	63.3	2.03	-350.3	48.4	-3.31	78	0.345	0.752	318	86.8	93.2	1	0.8	Stable	6	9.4	19876-2	19911-7	Pirfenidone	2,403	0	3.9	0.646	0	0	null	null	82.3	0	0	Mycophenolate	null	null	1,401	20	7.8	6.74	767.3	4.84	0	4.286	2,670.3	10.2	28	11.65	Stable	0	Negative	34.9	0	1.8	15088-0	TG_Het	0	0	0	0	0	38.2	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	18.4	37.7	0	0	0	null	0	null	0	Transplant	1	0	29.2	1	1	28	None_to_Exertional	2	81.7	54.6	31.8	1	0	0	0	1	1
HC007-000058	HP	31.3	Female	White_Non-Hispanic	Former_Smoker	54	Metal_Dust	Other	29.2	167.5	2,015	18	CA22	Indeterminate	24.2	0	0	38.4	1.9	Bilateral_Basal	29.9	1	0	0	32.8	Philips	1.73	64.4	2.19	-119.5	57.4	-4.94	83.5	0.472	0.774	311	81.7	93	0	0	Stable	2	0.2	19876-2	19911-7	Untreated	0	0	3.4	0.484	0	0	null	null	0	0	0	Mycophenolate	null	null	1,993	72.8	77.9	15.38	3,506.9	7.57	0	4.694	172.9	7.26	15.14	20.45	Increasing	1	Negative	14.3	0	4.3	15088-0	TT_Wildtype	0	1	0	0	0	30	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	35.5	62.1	0	0	0	null	0	null	0	Stable	0	0	20.4	0	1	0	Exertional_to_Continuous	2	47.9	47	57	3	0	0	0	0	1
HC007-000059	IPF	59.1	Male	White_Non-Hispanic	Former_Smoker	41.8	Mold	North_America	20.4	183.6	2,023	36	CB03.10	Probable_UIP	27.9	1	7.3	17.2	3.7	Bilateral_Basal	29.3	0	0	6.37	34	Philips	1.24	92.7	3.71	-186	60.1	-2.2	80	0.375	0.776	441	85	92.8	0	0	Stable	0	0	19876-2	19911-7	Nintedanib	0	300	2.7	0.554	1	1	GI_Intolerance	6.8	77.5	0	0	null	null	null	620	96.3	43.8	22.2	136.3	7.31	0	12.547	459.3	2.76	17.38	27.49	Increasing	0	Negative	6.6	0	2.9	15088-0	TT_Wildtype	0	0	0	0	0	0	1	0	0	0	null	0	0	0	0	null	0	0	null	null	1	46.8	56.5	0	0	0	null	0	null	0	Stable	0	0	3	1	1	9	Exertional_to_Continuous	2	51.8	22.7	65.7	3	1	0	1	1	1
HC007-000060	IPF	50.1	Female	Hispanic	Never	0	Asbestos	Europe	25	157.8	2,018	28	CB03.10	UIP	23.6	1	12.7	13.7	1.9	Bilateral_Basal	53.2	0	0	0	27.9	Philips	1.76	45.6	1.75	-181.7	50	-5.64	51.1	0.355	0.822	339	83.6	95.5	1	1.1	Improver	4	4.4	19876-2	19911-7	Nintedanib	0	150	1.3	0.808	1	0	null	null	170.6	0	0	null	null	null	702	28.5	50.4	6.3	466	4.02	1	10.726	1,041.5	10.58	15.01	31.6	Stable	0	Negative	9.6	0	2.2	15088-0	TT_Wildtype	1	0	0	0	0	43.3	0	1	0	0	null	0	0	0	0	null	0	0	null	null	0	28	33.8	0	0	0	null	0	null	0	Progression	0	0	15.3	0	1	0	Exertional_to_Continuous	2	70.1	59	39	5	1	0	1	1	1
HC007-000061	HP	50.1	Female	White_Non-Hispanic	Former_Smoker	12.9	Wood_Dust	Europe	16.3	166.1	2,018	20	CA22	Indeterminate	8.1	1	6.1	16.8	1.1	Bilateral_Basal	54.6	1	0	3.61	9.4	Siemens	0.77	63.9	1.48	-111.2	85.7	1	67.4	0.345	0.9	153	83	91.3	0	0	Slow_Decliner	2	0	19876-2	19911-7	Untreated	0	0	0.5	0.717	0	0	null	null	0	0	0	Mycophenolate	null	null	1,717	95.7	33.3	6.47	381.2	8.1	0	3.326	272.6	13.37	27.73	23.75	Stable	1	Negative	5.7	0	4.7	15088-0	TT_Wildtype	0	0	0	0	0	19.8	1	1	0	0	null	0	0	0	0	null	0	0	null	null	0	58	60.8	0	0	0	null	0	null	0	Stable	0	0	79.3	1	0	12	None_to_Exertional	2	80.7	45.1	0	4	0	0	0	0	1
HC007-000062	IPF	69.5	Male	White_Non-Hispanic	Former_Smoker	62	Bird_Antigen	North_America	28.8	175.4	2,011	40	CB03.10	Probable_UIP	27.1	1	9.4	2.1	2.3	Bilateral_Basal	38.6	0	0	2.71	32.3	Philips	1.45	73.4	2.83	-164	28.9	-2.47	89	0.4	0.846	444	86.6	99	1	1.7	Stable	5	0	19876-2	19911-7	Untreated	0	0	3.9	0.84	0	0	null	null	0	0	0	null	null	null	622	70.8	63.4	5.42	731.6	4.44	0	3.583	661.6	13.97	31.92	18.62	Stable	0	Negative	1	0	5.1	15088-0	TG_Het	1	0	0	0	0	69.2	0	0	1	1	Infection_Viral	0	0	0	0.469	Partial	750	0	13.5	-211.9	1	65.5	92.3	0	0	0	null	0	null	0	Death	1	0	7.1	1	1	33	None_to_Exertional	3	65.4	54.4	32	5	1	0	1	1	1
HC007-000063	HP	57.8	Male	East_Asian	Current	19.4	null	Other	24.9	167.9	2,017	4	CA22	Alternative_Dx	7	0	0	30.9	3.2	Diffuse	46.1	0	0	3.54	0	Siemens	0.67	96.8	3.55	-87.3	71.8	-3.11	78.1	0.383	0.766	451	74.9	95.7	0	0	Slow_Decliner	0	0	19876-2	19911-7	Trial_Drug	0	0	8.8	0.773	0	0	null	null	0	0	0	null	Pamrevlumab	Phase_II	356	152.7	45	8.31	504.1	3.24	1	9.648	366	4.58	13.63	12.59	Increasing	1	Negative	2.5	0	6.7	15088-0	TT_Wildtype	0	0	0	0	0	8.6	0	0	1	1	Idiopathic	1	0	0	0.817	Partial	500	0	5.4	-266.3	0	44.8	65.5	0	0	0	null	0	null	0	Progression	0	0	11.8	1	0	12	Exertional_to_Continuous	2	50.2	51.9	18.1	3	0	0	0	0	0
HC007-000064	CTD-ILD	52	Female	Hispanic	Former_Smoker	21.3	Asbestos	North_America	19.8	158.5	2,015	7	CB03.1Z	Alternative_Dx	4.3	0	0	5.3	0.9	Diffuse	32.5	0	0	0.81	5.9	Siemens	1.71	86.8	2.47	-103.7	56.2	-2.25	67.1	0.333	0.825	417	78	91.6	1	6	Slow_Decliner	1	0	19876-2	19911-7	Untreated	0	0	7.9	0.856	0	1	GI_Intolerance	11	0	1	29	null	null	null	479	52	16.9	13.28	455.8	6.52	0	2.559	585.1	11.06	22	35.74	Stable	0	Negative	6.6	0	2.3	15088-0	TG_Het	0	0	0	1	0	34.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	49.3	56.9	0	0	0	null	0	null	1	AE	0	0	57.1	0	0	0	None_to_Exertional	2	37.4	68	82.8	7	0	0	1	0	1
HC007-000065	HP	58.1	Female	Other	Former_Smoker	31.9	Asbestos	Europe	33.1	146.4	2,016	43	CA22	Alternative_Dx	7.3	0	0	15.7	2	Bilateral_Basal	12.2	0	0	3.94	16.2	Canon	0.85	103.1	3.15	-200.2	40.1	-7.14	89.1	0.396	0.815	98	91	95.9	0	0	Slow_Decliner	2	3.3	19876-2	19911-7	Untreated	0	0	5.4	0.704	0	0	null	null	0	0	0	null	null	null	485	74.2	9.5	23.14	665.8	7.21	0	14.475	950.1	17.57	37.96	33.83	Stable	1	Negative	5.3	0	2	15088-0	TT_Wildtype	0	0	0	0	0	2.3	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	22.6	36.7	0	0	0	null	0	null	1	Stable	0	0	8.9	0	0	0	None_to_Exertional	1	49.9	59.5	27	1	0	0	1	1	0
HC007-000066	HP	62.4	Male	Hispanic	Former_Smoker	35.2	Bird_Antigen	Europe	20.7	169.4	2,013	60	CA22	Indeterminate	9.6	0	0	7.8	2.6	Bilateral_Basal	19.6	0	1	3.63	11.7	Siemens	1.14	80.2	3.62	19.8	90	-4.49	73.2	0.347	0.799	360	87.7	97	0	0	Slow_Decliner	1	0	19876-2	19911-7	Untreated	0	0	3.7	0.806	0	0	null	null	0	0	0	null	null	null	3,321	81.8	8	17.22	300	4.38	0	6.561	330.3	28.94	10.34	40.19	Increasing	0	1:40-1:80	17.8	0	4.7	15088-0	TG_Het	0	0	0	0	0	22.1	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	44.2	68.4	0	0	0	null	0	null	1	Stable	0	0	55.6	1	1	30	Exertional_to_Continuous	0	55	56.1	26.1	3	0	0	1	0	0
HC007-000067	HP	47.9	Male	Black_Non-Hispanic	Former_Smoker	48.2	Bird_Antigen	Other	31.6	178.4	2,012	37	CA22	Alternative_Dx	20	0	0	31.6	1.7	Diffuse	55.1	1	1	9	22.4	Siemens	1.48	70.3	2.91	-52.1	90	0.07	78.6	0.224	0.819	445	83.4	95.1	0	0	Fast_Decliner	1	0	19876-2	19911-7	Pirfenidone	2,403	0	8	0.685	0	0	null	null	141.9	0	0	Mycophenolate	null	null	1,549	20	19.9	13.37	207.6	3.72	1	4.276	1,271.4	10.38	24.34	14.31	Increasing	0	Negative	16	0	2.1	15088-0	TG_Het	0	0	0	0	0	39.1	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	25.1	37.6	0	0	0	null	0	null	1	AE	0	0	30.7	1	0	24	Stable	3	51.7	9.9	35.1	4	0	0	0	1	1
HC007-000068	IPF	74.1	Female	White_Non-Hispanic	Former_Smoker	10.6	Bird_Antigen	Europe	23.9	162.5	2,023	20	CB03.10	UIP	41.3	0	0	4.8	1.7	Bilateral_Basal	35.7	0	0	3.47	42.5	Siemens	1.22	85.4	2.47	-62.9	46.7	-4.14	73.2	0.42	0.866	366	91.9	91	0	0	Stable	5	0	19876-2	19911-7	Pirfenidone	1,602	0	2	0.694	0	0	null	null	93.8	0	0	null	null	null	802	53.9	9.2	11.28	496.7	5.11	0	6.088	570.6	13.36	8.2	26.08	Increasing	1	Negative	4.2	0	2.9	15088-0	GG_Hom	1	0	0	0	0	90.1	0	0	1	1	Idiopathic	1	1	1	0.924	Complete	500	0	18.5	-397.9	0	21.3	41.2	0	0	0	null	0	null	1	Stable	0	0	16.2	1	1	10	Exertional_to_Continuous	3	40.1	39.2	73.7	3	1	0	1	1	0
HC007-000069	IPF	73.6	Female	White_Non-Hispanic	Never	0	null	North_America	35.8	155.4	2,017	53	CB03.10	Probable_UIP	12.1	1	3.8	4.9	3	Upper_Lobe	55.4	0	0	6.03	15.8	Philips	1.67	45.4	0.94	-202.6	57.1	-3.63	75.6	0.414	0.777	349	83.8	99	0	0	Stable	6	7.5	19876-2	19911-7	Nintedanib	0	300	0.5	0.583	1	0	null	null	147.1	1	13	Mycophenolate	null	null	595	70.2	11.7	13.41	207.3	4.92	0	13.69	1,744	4.97	16.64	17.35	Increasing	0	1:160+	2.6	0	2.1	15088-0	TG_Het	0	0	0	0	0	45.4	1	0	1	1	Procedure	0	0	0	0.468	Partial	1,000	1	28.4	-371.1	0	26.8	38.6	0	0	0	null	0	null	0	Progression	0	0	77.2	0	0	0	Exertional_to_Continuous	2	30.6	0	74.9	3	0	0	0	0	0
HC007-000070	IPF	70.9	Female	White_Non-Hispanic	Former_Smoker	39.9	Mold	East_Asia	31.4	158.4	2,015	60	CB03.10	Probable_UIP	50.2	0	0	14.1	0.5	Bilateral_Basal	56.9	0	0	0.05	54.2	Canon	1.53	39.2	0.85	-240.1	42.5	-4.43	76.6	0.392	0.799	415	84.1	95.9	0	0	Improver	8	16	19876-2	19911-7	Pirfenidone	2,403	0	3.9	0.844	1	0	null	null	64.7	0	0	Rituximab	null	null	1,521	20	19.7	13.81	295	7.72	0	1.684	249	4.66	15.55	25.11	Increasing	0	1:160+	20.2	0	6.9	15088-0	TG_Het	1	0	0	0	0	63.5	0	1	1	1	Infection_Viral	1	0	0	0.471	null	1,000	0	4.5	-182.4	0	40.1	50.7	0	0	0	null	0	null	1	AE	0	0	19.7	1	0	18	Stable	4	47.8	18	31.1	3	1	0	0	0	0
HC007-000071	IPF	72.6	Female	White_Non-Hispanic	Never	0	null	East_Asia	22.3	153.4	2,011	14	CB03.10	Probable_UIP	16.4	1	3.9	0.6	2.3	Upper_Lobe	39.3	0	1	5.34	24.6	Siemens	0.7	87.6	2.81	-32.6	45	-0.57	86.2	0.353	0.879	343	83.1	90.3	1	0.5	Slow_Decliner	5	0.3	19876-2	19911-7	Untreated	0	0	0.9	0.558	0	0	null	null	0	0	0	Mycophenolate	null	null	2,756	99.9	67.9	21.15	90.3	5.82	0	11.199	284.4	13.38	8.31	104.93	Stable	0	Negative	10.2	0	5.7	15088-0	TT_Wildtype	0	0	1	0	0	41.4	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	41.5	33.3	0	0	0	null	0	null	0	Stable	1	1	31.2	1	1	17	Exertional_to_Continuous	2	32.1	68.9	40.3	5	1	0	0	0	1
HC007-000072	IPF	70	Female	Black_Non-Hispanic	Former_Smoker	45.3	null	Europe	22.7	163.2	2,020	14	CB03.10	Indeterminate	46.8	0	0	12	4	Bilateral_Basal	21.9	1	1	3.68	47.2	GE	1.66	73.8	2.55	-271	31.9	-3.99	88	0.376	0.848	444	96.5	94.6	1	3.7	Stable	7	14.9	19876-2	19911-7	Trial_Drug	0	0	1.1	0.829	0	0	null	null	0	0	0	null	Pamrevlumab	Phase_III	1,471	70.2	6.6	10.91	347.4	6.83	0	12.388	379	2.95	25.42	38.54	Stable	0	Negative	3.9	0	1.3	15088-0	TT_Wildtype	0	0	0	0	0	11.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	1	41.1	50.9	0	0	0	null	0	null	0	Progression	1	1	31.7	0	0	0	Exertional_to_Continuous	1	13.6	36.3	47.4	1	0	0	1	0	0
HC007-000073	NSIP	85	Female	White_Non-Hispanic	Former_Smoker	12.9	null	East_Asia	30.6	165	2,016	3	CB03.11	Indeterminate	5.2	0	0	17	2.2	Diffuse	15.6	0	0	3.77	3.5	Philips	1.14	91.4	2.71	-224.8	37.5	-6	61.7	0.429	0.897	375	88.2	93.3	0	0	Stable	5	7.9	19876-2	19911-7	Pirfenidone	1,602	0	6.7	0.773	0	0	null	null	75.8	1	17	null	null	null	308	70	22.7	12.56	143.2	6.79	0	4.99	190.8	8.83	17.45	16.81	Stable	0	Negative	2.1	0	2.9	15088-0	TT_Wildtype	0	0	0	0	0	22.2	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	28	36.7	0	0	0	null	0	null	1	Death	0	0	24.9	1	0	10	Stable	3	27.8	68.4	88.2	3	0	0	0	0	1
HC007-000074	IPF	66.1	Female	White_Non-Hispanic	Former_Smoker	41.4	null	North_America	26.1	164.8	2,015	17	CB03.10	Probable_UIP	44.2	0	0	4.4	2.6	Bilateral_Basal	41.2	0	0	3.8	45.6	GE	1.4	54.7	2.06	-200.7	79.5	1	73	0.342	0.906	338	88	94	1	0.5	Fast_Decliner	5	0	19876-2	19911-7	Pirfenidone	2,403	0	1.8	0.841	0	0	null	null	148.8	1	26	null	null	null	439	102.8	8.2	8.99	320.6	8	0	5.795	852.5	16.7	11.35	21.62	Increasing	0	Negative	3.6	0	3	15088-0	GG_Hom	0	0	0	0	0	44.5	0	1	1	1	Idiopathic	1	0	0	0.49	null	1,000	0	8.1	-500	0	43.3	60.5	0	0	0	null	0	null	0	Progression	0	0	82.7	0	1	0	None_to_Exertional	3	35.6	29.8	0	5	1	1	0	1	0
HC007-000075	IPF	63.9	Male	White_Non-Hispanic	Never	0	Mold	Europe	26.6	164.8	2,019	3	CB03.10	UIP	36.1	1	3.9	10	3.2	Diffuse	30.4	0	0	6.78	48.9	Siemens	0.82	93.1	3.63	-123.2	49.4	-6.25	85.8	0.432	0.738	415	89.3	90.4	1	0.5	Stable	2	0	19876-2	19911-7	Nintedanib	0	150	3.9	0.671	0	0	null	null	183.2	0	0	Mycophenolate	null	null	921	52.1	14.2	11.67	124.3	4.55	0	6.566	422.8	11.66	18.75	20.47	Stable	0	Negative	13.1	0	0.8	15088-0	TT_Wildtype	0	0	0	0	0	0	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	33.7	48.7	0	0	0	null	0	null	0	Stable	1	0	70.4	1	0	43	None_to_Exertional	3	29.4	42.7	15.1	4	1	0	1	1	1
HC007-000076	IPF	59.5	Male	White_Non-Hispanic	Former_Smoker	43.8	Bird_Antigen	East_Asia	34.1	163.7	2,011	60	CB03.10	UIP	43.1	0	0	3.3	3.1	Bilateral_Basal	33.4	0	0	3.74	46.5	Siemens	1.13	82.1	3.33	-68.8	50.8	-3.69	66.2	0.292	0.837	292	77.7	94.2	1	1.4	Slow_Decliner	1	0	19876-2	19911-7	Pirfenidone	1,602	0	15.9	0.808	1	0	null	null	92.1	0	0	null	null	null	1,497	68.4	46.7	9.7	324.6	5.68	0	9.394	199.9	11.62	23.61	26.1	Decreasing	0	Negative	61.8	0	2.5	15088-0	TG_Het	0	1	0	0	0	46.1	0	0	1	1	Idiopathic	0	0	0	0.628	Complete	750	0	27.6	-233.8	0	43.5	58.1	0	0	0	null	0	null	0	Death	1	1	62.2	1	0	17	None_to_Exertional	1	47.4	48.5	115.2	1	1	0	0	1	1
HC007-000077	IPF	56.7	Male	White_Non-Hispanic	Former_Smoker	37.5	Mold	North_America	23.6	188.4	2,017	60	CB03.10	Probable_UIP	29.7	1	16.4	2.1	2	Bilateral_Basal	26	0	0	1.55	29.9	GE	1.73	69.4	2.82	-116.9	37	-5.18	49.7	0.39	0.79	226	84	91.5	1	0.5	Slow_Decliner	2	0	19876-2	19911-7	Pirfenidone	2,403	0	12.6	0.853	1	0	null	null	149.3	0	0	null	null	null	863	112.1	11.3	6.08	742.3	3.6	1	3.905	250.6	7.97	8.11	11.45	Increasing	0	1:160+	6.3	0	4.9	15088-0	GG_Hom	0	1	0	0	0	69	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	39.2	59.8	0	0	0	null	0	null	0	Transplant	1	1	66.1	1	0	4	None_to_Exertional	1	20.6	76.4	82.6	4	0	0	1	0	0
HC007-000078	HP	45.1	Female	White_Non-Hispanic	Never	0	null	Europe	28	159.1	2,022	5	CA22	Alternative_Dx	19	1	17.3	33.8	2.3	Diffuse	49.7	0	0	1.91	10.4	Siemens	1.89	77.7	2.87	-91.9	61	-4.9	55.3	0.382	0.748	360	89.3	93	0	0	Stable	1	0	19876-2	19911-7	Trial_Drug	0	0	6	0.951	0	0	null	null	0	1	28	Mycophenolate	Inhaled_Treprostinil	Phase_III	1,822	68.9	18	17.06	193.2	7.64	0	5.997	242.5	6.65	4.67	28.84	Increasing	1	Negative	3	1	0.8	15088-0	TT_Wildtype	0	0	0	0	0	16.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	20.4	20	0	0	0	null	0	null	1	Progression	0	0	35.8	1	0	11	Stable	1	22.5	65.6	13.3	5	0	0	1	1	1
HC007-000079	HP	49.3	Male	Black_Non-Hispanic	Former_Smoker	20	null	Other	32.5	171.6	2,016	60	CA22	Indeterminate	10.5	1	3.4	6.9	1	Bilateral_Basal	37.3	1	0	4.92	7	Philips	1.91	80.2	3.41	-3.7	33.9	-5.62	56.2	0.44	0.773	416	87	95.2	0	0	Slow_Decliner	2	10.1	19876-2	19911-7	Pirfenidone	2,403	0	7.3	0.851	0	0	null	null	63.2	0	0	Azathioprine	null	null	1,302	22.1	24.8	23.2	142.6	8.06	0	5.698	851.1	23.98	16.17	8.51	Decreasing	1	Negative	108.7	0	6.1	15088-0	TT_Wildtype	0	0	0	0	0	13.5	1	0	1	1	Idiopathic	1	0	0	0.412	Complete	750	0	15.5	-184.4	0	33.8	46.4	0	0	0	null	0	null	0	AE	0	0	26	0	0	0	None_to_Exertional	4	65.8	35.6	120	6	0	0	0	0	1
HC007-000080	CTD-ILD	54.2	Female	White_Non-Hispanic	Former_Smoker	33.7	Mold	East_Asia	31.7	162.5	2,010	26	CB03.1Z	Indeterminate	5.3	0	0	9.3	2.4	Bilateral_Basal	26.7	0	0	4.14	8.5	Siemens	1.55	58.6	1.28	-125.9	45.6	-4.58	61.6	0.325	0.802	448	98	92.6	0	0	Stable	3	0	19876-2	19911-7	Untreated	0	0	6.5	0.741	0	0	null	null	0	0	0	null	null	null	708	68.8	38.9	10.82	667.5	7.72	0	9.091	614	15.13	12.09	10.63	Stable	0	Negative	5.2	0	1.9	15088-0	TT_Wildtype	0	0	0	0	0	17.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	48.5	52.1	0	0	0	null	0	null	0	AE	0	0	69.2	1	1	8	Exertional_to_Continuous	1	59.9	35.7	68.6	3	0	0	0	0	1
HC007-000081	HP	64	Female	Hispanic	Current	27.8	Wood_Dust	East_Asia	26.7	172	2,013	3	CA22	Probable_UIP	14.3	0	0	17.6	1.1	Bilateral_Basal	31.1	0	1	0	18.3	Philips	0.62	67.1	2.37	-149.7	38.8	-1.53	57.6	0.331	0.802	448	84.3	93.1	1	4.8	Slow_Decliner	4	2.3	19876-2	19911-7	Untreated	0	0	2.7	0.755	0	1	GI_Intolerance	4.5	0	1	22	null	null	null	1,284	69.3	14.3	13.01	751.4	6.33	0	30.122	406.3	12.47	28.09	66.74	Stable	1	Negative	3.1	0	3.2	15088-0	TT_Wildtype	0	0	0	0	0	28.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	52.1	55.1	0	0	0	null	0	null	0	Progression	1	1	17.5	1	0	31	Exertional_to_Continuous	1	48.6	49.4	54.9	4	0	0	0	1	1
HC007-000082	IPF	67.5	Male	East_Asian	Former_Smoker	32.9	null	North_America	26	165.5	2,010	60	CB03.10	UIP	41.8	1	16.5	3	2.4	Diffuse	34.2	0	0	4.28	42.7	Philips	1.16	76	3.75	-291.4	70.7	-7.3	82.4	0.296	0.784	323	91.7	96.5	1	3.3	Stable	2	0	19876-2	19911-7	Pirfenidone	801	0	6.2	0.853	1	0	null	null	223.8	0	0	Mycophenolate	null	null	454	114.5	60.9	16.96	483.7	3.71	1	3.895	345.3	8.28	14.18	20.48	Stable	1	Negative	5	0	0.5	15088-0	TT_Wildtype	0	0	0	0	0	20.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	27.2	37.9	0	0	0	null	0	null	0	Stable	0	0	11.6	0	0	0	Stable	2	68.2	93.4	90.4	3	1	0	0	1	1
HC007-000083	CTD-ILD	45.8	Female	White_Non-Hispanic	Former_Smoker	19	null	Other	18.5	155.1	2,017	17	CB03.1Z	Probable_UIP	13.5	1	10.2	10.9	0.9	Upper_Lobe	33.9	1	1	0.93	11.9	GE	0.79	66.3	1.98	-125.7	31.6	-0.98	64.1	0.346	0.819	344	91	91.3	0	0	Improver	4	6	19876-2	19911-7	Untreated	0	0	4.3	0.667	0	0	null	null	0	0	0	Mycophenolate	null	null	423	54.3	15.5	10.26	217.3	6.38	0	6.343	377.2	6.1	18.61	50.06	Increasing	0	Negative	4.7	0	5.9	15088-0	TT_Wildtype	0	0	0	1	0	8.9	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	32.8	46	0	0	0	null	0	null	0	Stable	0	0	77	1	1	20	Exertional_to_Continuous	2	30.1	47.4	29.3	3	0	1	0	0	1
HC007-000084	IPF	76	Female	White_Non-Hispanic	Former_Smoker	26.1	null	North_America	22	166.7	2,015	60	CB03.10	Indeterminate	37.2	0	0	7.1	2.1	Bilateral_Basal	49.8	0	0	4.12	50.2	Philips	1.55	43.6	1.08	-75.5	31.1	-1.32	85.7	0.395	0.96	274	87.7	92.1	0	0	Slow_Decliner	8	23.9	19876-2	19911-7	Untreated	0	0	8.7	0.66	0	0	null	null	0	0	0	null	null	null	579	37.1	32.7	12.12	187.4	4.85	0	3.832	1,551.2	14.01	15.26	16.36	Increasing	0	Negative	37.5	0	0.7	15088-0	TT_Wildtype	1	0	0	0	0	19.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	36.6	53.6	0	0	0	null	0	null	0	Stable	1	0	63.5	1	0	7	Exertional_to_Continuous	3	56.2	29.4	39.4	5	0	1	0	1	1
HC007-000085	IPF	74.4	Female	Hispanic	Former_Smoker	38.6	null	Europe	29.2	166.5	2,011	16	CB03.10	UIP	49.4	0	0	1.5	2.3	Diffuse	30	0	0	1.51	67.8	Siemens	0.74	75.3	2.59	-157.5	18	-2.48	52.2	0.272	0.716	354	88.6	90.2	0	0	Stable	6	22	19876-2	19911-7	Nintedanib	0	300	1.6	0.947	0	1	Progression	24	202	0	0	null	null	null	1,570	37.2	19.1	9.89	245.1	7.09	0	4.512	378.5	7	8.86	8.58	Stable	0	1:160+	1.1	0	0.5	15088-0	TT_Wildtype	0	0	0	0	0	6.4	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	56.1	72.6	0	0	0	null	0	null	0	Stable	1	0	41.9	0	0	0	Exertional_to_Continuous	2	39.4	30.4	54	3	0	1	1	0	0
HC007-000086	IPF	65.4	Male	White_Non-Hispanic	Former_Smoker	28.3	null	Europe	26.8	171.8	2,019	9	CB03.10	Alternative_Dx	35.6	1	1	6.6	2.4	Upper_Lobe	32.5	0	1	2.61	44.9	Siemens	1.97	85	4.16	-91.6	35.8	-3.25	63.1	0.353	0.888	174	85.5	91.5	1	2.7	Stable	3	9.1	19876-2	19911-7	Pirfenidone	2,403	0	11	0.782	1	0	null	null	116.1	0	0	Azathioprine	null	null	586	158.5	40.2	8.37	313.2	5.2	0	3.172	812.6	8.49	16.65	14.51	Stable	1	1:40-1:80	16.7	0	1.1	15088-0	TT_Wildtype	0	0	0	0	0	25.7	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	47.6	54	0	0	0	null	0	null	0	Stable	0	0	22.6	0	0	0	None_to_Exertional	1	69.6	42.3	65.1	4	1	0	1	1	1
HC007-000087	CTD-ILD	47.2	Female	Black_Non-Hispanic	Never	0	null	East_Asia	27.9	167.9	2,012	30	CB03.1Z	Probable_UIP	5.4	0	0	9.7	0.8	Diffuse	21.9	0	0	2.06	13.7	GE	0.79	93.2	3.14	-38.6	50.6	-2.95	69.5	0.417	0.819	362	77.1	94.4	0	0	Fast_Decliner	2	0	19876-2	19911-7	Untreated	0	0	6.7	0.638	0	0	null	null	0	0	0	null	null	null	635	79.3	112.4	14.31	69.9	5.87	0	2.415	354.1	11.11	9.67	94.07	Increasing	0	1:160+	8.1	0	0.6	15088-0	TT_Wildtype	0	0	0	0	1	11	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	26.6	38	0	0	0	null	0	null	0	Stable	0	0	79.9	1	0	23	Exertional_to_Continuous	2	46.9	52.3	60.8	1	0	1	0	0	0
HC007-000088	IPF	72.5	Male	White_Non-Hispanic	Former_Smoker	44.4	Bird_Antigen	Other	32.9	171.6	2,014	6	CB03.10	Probable_UIP	21.1	0	0	9.5	2.5	Bilateral_Basal	21.4	0	1	6.39	32.1	Philips	0.58	79.6	2.86	-150.7	65.6	-0.65	79.3	0.374	0.794	601	88.7	95.9	0	0	Fast_Decliner	3	0	19876-2	19911-7	Nintedanib	0	300	0.8	0.717	0	1	GI_Intolerance	36	87.8	0	0	null	null	null	1,069	153.7	17.8	14.24	136.3	8.84	0	12.301	1,447.7	9.07	9.49	12.12	Increasing	0	Negative	4.2	0	4.6	15088-0	TT_Wildtype	0	0	0	0	0	20.4	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	47.9	72.4	0	0	0	null	0	null	1	Stable	1	1	43.7	0	1	0	None_to_Exertional	2	26.9	27.9	57.3	2	1	0	1	1	0
HC007-000089	IPF	68.9	Female	White_Non-Hispanic	Never	0	Asbestos	Europe	21.3	152.1	2,023	53	CB03.10	UIP	35.4	1	5.1	12.7	2	Bilateral_Basal	41.8	0	0	4.04	50	Philips	1.77	84.7	2.85	-118.4	46.4	-6.99	84	0.385	0.699	187	89.1	91.6	1	0.5	Slow_Decliner	4	0	19876-2	19911-7	Nintedanib	0	150	7.8	0.812	0	0	null	null	146.8	0	0	Mycophenolate	null	null	1,826	167.6	21.9	17.48	1,018.2	6.92	0	7.491	189.9	17.73	10.6	59.64	Decreasing	1	Negative	5.5	0	1	15088-0	TT_Wildtype	0	0	0	0	0	20.1	1	0	1	2	Infection_Viral	0	0	0	0.526	null	1,000	0	7.4	-239.2	0	57.2	83.1	0	0	0	null	0	null	0	Progression	1	0	3	1	0	75	None_to_Exertional	3	67.3	65	41.7	3	0	0	1	1	0
HC007-000090	HP	42.6	Female	Hispanic	Current	28	null	Europe	26.3	165.2	2,010	60	CA22	Alternative_Dx	30.5	0	0	20.2	0.6	Bilateral_Basal	59.9	1	0	5.85	32	GE	0.8	91.8	2.97	-115.8	51.4	-2.05	60.5	0.29	0.866	375	89.9	95.8	0	0	Stable	2	0	19876-2	19911-7	Untreated	0	0	18	0.729	0	0	null	null	0	0	0	Azathioprine	null	null	389	42.7	15.7	11	398.1	8.01	0	6.396	784.4	4.22	10.24	29.15	Stable	1	1:160+	6	0	0.8	15088-0	TG_Het	0	0	0	0	0	34.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	44.6	55.1	0	0	0	null	0	null	0	Progression	0	0	31	1	0	19	Exertional_to_Continuous	2	35.5	32.9	61.2	2	0	0	0	1	0
HC007-000091	IPF	66.3	Male	White_Non-Hispanic	Former_Smoker	52.9	null	North_America	28.5	173.6	2,013	9	CB03.10	Probable_UIP	27.9	0	0	13.6	1.7	Bilateral_Basal	43.4	0	0	9.28	26.3	Philips	0.54	71.4	2.71	-136.5	54.8	-4.99	81.9	0.374	0.734	366	87.3	94.3	1	2.7	Slow_Decliner	4	0	19876-2	19911-7	Nintedanib	0	300	2.2	0.893	0	0	null	null	194.2	0	0	Azathioprine	null	null	1,646	40.8	13.9	6.05	996.5	5.08	0	3.581	262	8.45	15.12	26.05	Increasing	0	Negative	9.1	0	3.5	15088-0	GG_Hom	0	0	0	0	0	54.3	0	0	1	1	Idiopathic	1	1	1	0.898	null	1,000	0	8.2	-289.9	0	32.7	46.4	0	0	0	null	0	null	0	Death	0	0	62.7	1	0	6	Stable	3	21.5	72	59	0	0	0	1	0	0
HC007-000092	CTD-ILD	58.1	Male	White_Non-Hispanic	Never	0	Metal_Dust	Europe	23.8	181.6	2,014	49	CB03.1Z	Indeterminate	9.9	0	0	3.9	2	Bilateral_Basal	45.5	0	0	3.3	20.1	Siemens	1.32	35.9	1.89	-83.6	50.9	-1.85	44.5	0.382	0.87	408	91.9	89.9	0	0	Stable	4	12.6	19876-2	19911-7	Untreated	0	0	2	0.654	0	0	null	null	0	0	0	null	null	null	284	61.8	12.7	19.18	823.9	4.96	0	5.784	2,099.2	23.78	14.06	16.87	Increasing	0	1:40-1:80	4.8	0	0.8	15088-0	TT_Wildtype	0	0	0	0	0	9.7	1	0	0	0	null	0	0	0	0	null	0	0	null	null	0	52.2	58	0	0	0	null	0	null	0	Progression	0	0	25.3	0	1	0	Exertional_to_Continuous	2	70.1	51.2	51.7	0	0	1	0	0	0
HC007-000093	IPF	58	Male	Other	Never	0	null	Europe	34.9	159.9	2,017	43	CB03.10	Indeterminate	17.9	0	0	8.3	1.5	Diffuse	37.6	0	0	6.35	14.9	Siemens	1.95	90.9	3.95	-123.4	88.6	-4.73	80.2	0.37	0.924	238	82.7	94.5	0	0	Stable	0	0	19876-2	19911-7	Nintedanib	0	150	6.1	0.936	1	0	null	null	140.7	0	0	null	null	null	611	96.4	21.9	7.63	249.3	7.29	0	3.023	726.4	12.79	18.42	15.63	Stable	0	Negative	7.5	0	1.7	15088-0	TT_Wildtype	0	0	0	0	0	32.8	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	44.2	65.4	0	0	0	null	0	null	0	Death	0	0	42.9	0	0	0	Exertional_to_Continuous	0	54.1	39.4	45.1	2	0	0	1	1	1
HC007-000094	IPF	68.9	Male	White_Non-Hispanic	Current	1	Asbestos	North_America	32.2	184.3	2,013	60	CB03.10	UIP	36.8	1	7.7	8.8	2.9	Bilateral_Basal	25.6	0	0	1.73	35.3	Siemens	0.9	53.9	2.66	-39.4	40.5	-2.09	49.2	0.389	0.743	379	94.3	97.6	1	0.5	Slow_Decliner	5	0	19876-2	19911-7	Nintedanib	0	300	8.5	0.614	0	1	GI_Intolerance	36	142.6	0	0	null	null	null	1,086	28.8	11.9	7.57	252.7	7.89	0	5.952	135.3	7.4	8.76	32.53	Increasing	0	Negative	3.2	0	0.8	15088-0	TT_Wildtype	0	0	0	0	0	7.4	1	1	1	1	Idiopathic	1	0	0	0.722	Partial	750	0	9	-63.8	0	39	70.5	0	0	0	null	0	null	0	Stable	0	0	9.1	0	1	0	Exertional_to_Continuous	4	27.1	0	38.5	3	0	0	1	1	1
HC007-000095	IPF	52.5	Female	White_Non-Hispanic	Former_Smoker	26.9	null	Europe	29	166.3	2,023	3	CB03.10	UIP	36.9	0	0	14.1	2.4	Bilateral_Basal	29.3	1	0	5.84	35.6	Canon	1.11	49.6	1.22	-254	56.6	-6.6	74.3	0.361	0.89	279	82.1	88.3	1	2.8	Fast_Decliner	3	0.9	19876-2	19911-7	Nintedanib	0	300	5.5	0.615	1	0	null	null	124.2	0	0	null	null	null	2,769	87.6	12.2	8.45	788.3	4	1	7.391	232.3	12.18	14.87	47.45	Stable	0	Negative	112	0	1.3	15088-0	TT_Wildtype	0	0	0	0	0	24	0	0	1	1	Idiopathic	1	1	1	0.736	null	1,000	1	13.5	-160.7	0	52.7	61.4	0	0	0	null	0	null	0	Stable	0	0	5	1	0	9	Exertional_to_Continuous	3	40.7	39	13.9	4	1	0	0	0	1
HC007-000096	HP	76	Male	White_Non-Hispanic	Former_Smoker	14.5	Bird_Antigen	East_Asia	36.8	185	2,010	7	CA22	Probable_UIP	17.7	0	0	23.9	0.1	Bilateral_Basal	33.5	1	1	1.5	18.8	GE	0.86	54.1	2.39	-70.4	71.2	-6.89	83.8	0.353	0.822	224	86.5	99	0	0	Slow_Decliner	5	0	19876-2	19911-7	Untreated	0	0	0.5	0.947	0	0	null	null	0	0	0	Mycophenolate	null	null	499	85	1.8	4.61	653.8	5.78	0	4.369	720.3	7.97	13.56	27.06	Decreasing	1	Negative	27.4	0	6.8	15088-0	GG_Hom	0	0	0	0	0	61.6	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	42	64.4	0	0	0	null	0	null	0	AE	0	0	54.7	1	1	4	Exertional_to_Continuous	2	40.2	46.5	89	5	0	0	1	0	1
HC007-000097	IPF	79.5	Male	White_Non-Hispanic	Former_Smoker	27	null	Europe	19.7	174.6	2,023	16	CB03.10	Probable_UIP	28.9	1	5.2	2.3	1.6	Bilateral_Basal	50.6	1	0	3.16	21.9	GE	1.34	112	4.44	-59.8	40.1	-3.73	80.4	0.318	0.694	420	90.4	92.2	0	0	Stable	4	0	19876-2	19911-7	Untreated	0	0	0.5	0.892	0	0	null	null	0	0	0	Rituximab	null	null	346	33.9	67.2	9.89	803.3	4.52	0	3.842	706.6	17	17.82	35.51	Stable	0	1:40-1:80	14.7	0	3.3	15088-0	TG_Het	0	0	0	0	0	39.9	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	43	61.9	0	0	0	null	0	null	0	Progression	1	1	7.2	1	0	15	Stable	0	26.5	47.4	71.5	2	0	0	0	0	1
HC007-000098	IPF	64.5	Male	East_Asian	Former_Smoker	26.5	null	East_Asia	27.5	183.1	2,017	7	CB03.10	UIP	36	0	0	8.8	1.4	Diffuse	31.1	0	1	4.33	32.4	Philips	0.98	77.9	3.35	-260.3	52.6	-0.63	45.1	0.438	0.748	393	84.4	89.1	0	0	Stable	2	0	19876-2	19911-7	Untreated	0	0	4.6	0.66	0	0	null	null	0	0	0	Azathioprine	null	null	619	34.7	82.7	15.02	326.3	6.47	0	4.502	670.6	12.31	18.17	19.83	Decreasing	0	1:160+	4.8	0	0.4	15088-0	TT_Wildtype	1	0	0	0	0	39	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	52.3	64	0	0	0	null	0	null	0	Progression	0	0	15.8	1	1	2	Exertional_to_Continuous	2	27.2	58.2	78.2	4	0	0	1	1	0
HC007-000099	IPF	70.6	Male	East_Asian	Former_Smoker	22.9	Mold	North_America	29.4	163.2	2,010	18	CB03.10	UIP	24.9	0	0	2.1	3	Bilateral_Basal	42.5	0	0	4.66	24.3	Siemens	1.39	51.3	2.6	-87.8	42	-2.43	61.7	0.306	0.831	238	90.7	94.4	1	0.9	Slow_Decliner	6	14.4	19876-2	19911-7	Nintedanib	0	300	2.8	0.711	0	0	null	null	93.7	0	0	null	null	null	916	87.1	37.3	8.87	375.5	7.32	0	9.864	497.5	5.29	17.51	72.71	Increasing	0	1:160+	21.9	0	0.9	15088-0	TT_Wildtype	0	0	0	1	0	3.2	0	1	0	0	null	0	0	0	0	null	0	0	null	null	0	36	43.4	0	0	0	null	0	null	0	AE	1	0	65.4	1	1	9	Stable	3	40.8	38.7	21.9	5	0	0	1	1	0
HC007-000100	SR-ILD	35	Female	White_Non-Hispanic	Former_Smoker	29.3	Asbestos	Europe	22.7	155.7	2,011	3	CB03.13	Indeterminate	9.4	1	6.9	1	1.6	Upper_Lobe	37.6	0	0	0.53	4.4	Siemens	1.22	61.7	1.48	-105.6	62.4	-2.44	78	0.389	0.844	308	85.3	96.5	0	0	Slow_Decliner	2	1.2	19876-2	19911-7	Untreated	0	0	6.5	0.598	0	0	null	null	0	0	0	null	null	null	2,220	231.3	11	21.52	262.4	5.98	0	6.828	356.6	9.2	11.07	27.64	Increasing	0	1:160+	11.7	0	3.7	15088-0	TT_Wildtype	1	1	0	0	0	45.8	0	0	0	0	null	0	0	0	0	null	0	0	null	null	0	28.1	60.9	0	0	0	null	0	null	0	Progression	1	1	12.9	1	1	27	None_to_Exertional	3	60.3	58.5	39	2	0	0	0	1	1

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.